Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MTA2 NOLC1 NPM1 MYBBP1A ANK2 MAPT RBM33 NACA BCORL1 NUP98 HIP1R SSX9P ZC3H18 SSX7 WNK1 TRDN JMJD1C FAN1 PPP2R3A MDC1 NUCKS1 H2AX DYNC1LI1 ZNF598	4.16e-07	1160	130	24	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	MTA2 NOLC1 NPM1 MYBBP1A ANK2 MAPT RBM33 NACA BCORL1 NUP98 HIP1R SSX9P ZC3H18 SSX7 DZIP1 WNK1 TRDN JMJD1C FAN1 PPP2R3A MDC1 NUCKS1 H2AX DYNC1LI1 ZNF598	1.91e-06	1356	130	25	GO:0060090
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	CFAP47 NPM1 MAP4 MAPT PPP1R12A APC NCKAP5 TACC2 DZIP1 CLIP1 TRDN NEFM FSIP2 CEP120 NAV3 NAV1 DYNC1LI1 SMN1 HYDIN DYNC1LI2 SON	5.33e-09	720	131	21	GO:0000226
GeneOntologyBiologicalProcess	microtubule-based process	CFAP47 NPM1 MAP4 MAPT PPP1R12A LCA5L APC NCKAP5 TACC2 DZIP1 CLIP1 TRDN NEFM FSIP2 RASGRP1 CEP120 NAV3 NAV1 DYNC1LI1 SMN1 TXNDC2 HYDIN DYNC1LI2 SON	4.91e-08	1058	131	24	GO:0007017
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	NPM1 ABI3BP MYCBP2 MAP4 MAPT SLITRK4 HIP1R APC DZIP1 REST MORC2 CLIP1 ADD3 PTPN13 CEP120 ANLN CASKIN1 NAV3 AHR LMOD1 PEAK1 RAPGEF2 ADGRL2	1.58e-06	1189	131	23	GO:0044087
GeneOntologyBiologicalProcess	cytoplasmic microtubule organization	MAPT APC TACC2 CLIP1 TRDN CEP120	3.89e-06	66	131	6	GO:0031122
GeneOntologyBiologicalProcess	negative regulation of organelle organization	NPM1 LIMA1 MAP4 MAPT DCP2 HIP1R APC ADD3 PARP1 NAV3 DYNC1LI1 LMOD1	1.59e-05	421	131	12	GO:0010639
GeneOntologyBiologicalProcess	cellular response to nerve growth factor stimulus	MAPT PARP1 DYNC1LI1 RAPGEF2 DYNC1LI2	3.64e-05	59	131	5	GO:1990090
GeneOntologyBiologicalProcess	protein depolymerization	LIMA1 APC NCKAP5 ADD3 NAV3 LMOD1 SMN1	3.79e-05	144	131	7	GO:0051261
GeneOntologyBiologicalProcess	response to nerve growth factor	MAPT PARP1 DYNC1LI1 RAPGEF2 DYNC1LI2	4.28e-05	61	131	5	GO:1990089
GeneOntologyBiologicalProcess	cell junction assembly	FN1 ANK2 ABI3BP MYCBP2 MAPT SLITRK4 APC PTPN13 CASKIN1 PEAK1 RAPGEF2 ADGRL2 GABRA2	6.95e-05	569	131	13	GO:0034329
GeneOntologyBiologicalProcess	microtubule-based movement	CFAP47 MAP4 MAPT LCA5L DZIP1 NEFM FSIP2 RASGRP1 DYNC1LI1 TXNDC2 HYDIN DYNC1LI2	7.36e-05	493	131	12	GO:0007018
GeneOntologyBiologicalProcess	positive regulation of cellular component biogenesis	MAPT SLITRK4 HIP1R APC DZIP1 MORC2 CLIP1 CEP120 ANLN NAV3 AHR LMOD1 ADGRL2	8.72e-05	582	131	13	GO:0044089
GeneOntologyBiologicalProcess	positive regulation of microtubule polymerization	MAPT APC CLIP1 NAV3	8.72e-05	37	131	4	GO:0031116
GeneOntologyBiologicalProcess	regulation of cellular component size	NPM1 LIMA1 FN1 MAPT HIP1R WNK1 ADD3 NEFM EIF4G2 AHR LMOD1	8.84e-05	426	131	11	GO:0032535
GeneOntologyBiologicalProcess	microtubule polymerization or depolymerization	MAP4 MAPT APC NCKAP5 CLIP1 NAV3 SMN1	1.00e-04	168	131	7	GO:0031109
GeneOntologyBiologicalProcess	positive regulation of microtubule polymerization or depolymerization	MAPT APC CLIP1 NAV3	1.44e-04	42	131	4	GO:0031112
GeneOntologyBiologicalProcess	regulation of anatomical structure size	NPM1 LIMA1 FN1 MAPT HIP1R WNK1 ADD3 NEFM EIF4G2 AHR LMOD1 PLEKHA7 NOS1	1.58e-04	618	131	13	GO:0090066
GeneOntologyBiologicalProcess	chromatin organization	MTA2 NPM1 MYBBP1A BCORL1 REST MORC2 UBN2 JMJD1C PCGF6 BRD2 MDC1 CFDP1 SYCP1 NUCKS1 H2AX TET3	1.81e-04	896	131	16	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	MTA2 NPM1 MYBBP1A BCORL1 REST MORC2 UBN2 JMJD1C PCGF6 BRD2 MDC1 CFDP1 SYCP1 AHR NUCKS1 H2AX TET3	1.99e-04	999	131	17	GO:0071824
GeneOntologyBiologicalProcess	negative regulation of cytoskeleton organization	NPM1 LIMA1 HIP1R APC ADD3 NAV3 LMOD1	2.44e-04	194	131	7	GO:0051494
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	LIMA1 APC ADD3 NAV3 LMOD1	2.59e-04	89	131	5	GO:1901880
GeneOntologyBiologicalProcess	regulation of organelle organization	NPM1 LIMA1 ABI3BP MYCBP2 MAP4 MAPT DCP2 HIP1R APC DZIP1 STOX1 MORC2 CLIP1 ADD3 PARP1 CEP120 CASKIN1 NAV3 DYNC1LI1 LMOD1	3.09e-04	1342	131	20	GO:0033043
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	FN1 ABI3BP MYCBP2 MAP4 MAPT APC DZIP1 CLIP1 NEFM NEO1 CEP120 ANLN EIF4G2 SMN1 RAPGEF2	3.15e-04	846	131	15	GO:0120035
GeneOntologyBiologicalProcess	regulation of protein-containing complex disassembly	LIMA1 APC WNK1 ADD3 NAV3 LMOD1	3.19e-04	144	131	6	GO:0043244
GeneOntologyBiologicalProcess	microtubule bundle formation	CFAP47 NCKAP5 CLIP1 FSIP2 NAV1 HYDIN	3.31e-04	145	131	6	GO:0001578
GeneOntologyBiologicalProcess	positive regulation of cytoskeleton organization	MAPT APC CLIP1 ADD3 CEP120 NAV3 LMOD1	3.41e-04	205	131	7	GO:0051495
GeneOntologyBiologicalProcess	regulation of cell projection organization	FN1 ABI3BP MYCBP2 MAP4 MAPT APC DZIP1 CLIP1 NEFM NEO1 CEP120 ANLN EIF4G2 SMN1 RAPGEF2	3.88e-04	863	131	15	GO:0031344
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	NPM1 LIMA1 MAP4 MAPT DCP2 HIP1R APC ADD3 PARP1 NEO1 PTPN13 NAV3 DYNC1LI1 LMOD1 RAPGEF2	3.93e-04	864	131	15	GO:0051129
GeneOntologyBiologicalProcess	negative regulation of protein-containing complex disassembly	LIMA1 APC ADD3 NAV3 LMOD1	4.45e-04	100	131	5	GO:0043242
GeneOntologyBiologicalProcess	cell junction organization	FN1 ANK2 ABI3BP MYCBP2 MAPT SLITRK4 HIP1R APC REST PTPN13 CASKIN1 PEAK1 RAPGEF2 ADGRL2 PLEKHA7 GABRA2	4.58e-04	974	131	16	GO:0034330
GeneOntologyBiologicalProcess	positive regulation of protein polymerization	MAPT APC CLIP1 NAV3 LMOD1	4.87e-04	102	131	5	GO:0032273
GeneOntologyBiologicalProcess	protein-containing complex disassembly	LIMA1 APC NCKAP5 WNK1 ADD3 NAV3 LMOD1 SMN1	5.52e-04	291	131	8	GO:0032984
GeneOntologyBiologicalProcess	regulation of protein depolymerization	LIMA1 APC ADD3 NAV3 LMOD1	5.56e-04	105	131	5	GO:1901879
GeneOntologyBiologicalProcess	regulation of microtubule-based process	NPM1 MAPT APC TACC2 CLIP1 CEP120 NAV3 DYNC1LI1	5.77e-04	293	131	8	GO:0032886
GeneOntologyBiologicalProcess	regulation of excitatory synapse assembly	ABI3BP PTPN13 CASKIN1	5.85e-04	26	131	3	GO:1904889
GeneOntologyBiologicalProcess	positive regulation of centrosome duplication	NPM1 CEP120	5.91e-04	6	131	2	GO:0010825
GeneOntologyCellularComponent	centrosome	NPM1 PPP1R12A KIAA0586 APC TACC2 DZIP1 STOX1 CLIP1 LUZP1 MYOF CEP120 MTUS1 CCNB3 CAPN7 H2AX DYNC1LI1 PLEKHA7 DYNC1LI2	1.37e-06	770	130	18	GO:0005813
GeneOntologyCellularComponent	microtubule organizing center	NPM1 MAP4 PPP1R12A KIAA0586 APC TACC2 DZIP1 STOX1 CLIP1 LUZP1 MYOF CEP120 MTUS1 CCNB3 CAPN7 H2AX DYNC1LI1 PLEKHA7 DYNC1LI2	4.11e-06	919	130	19	GO:0005815
GeneOntologyCellularComponent	chromosomal region	MTA2 PPP1R12A NUP98 APC CLIP1 PARP1 CFDP1 SYCP1 H2AX DYNC1LI1 DYNC1LI2 MAJIN	1.29e-05	421	130	12	GO:0098687
GeneOntologyCellularComponent	condensed chromosome	PPP1R12A NUP98 APC CLIP1 ADD3 CFDP1 SYCP1 H2AX DYNC1LI1 DYNC1LI2	2.27e-05	307	130	10	GO:0000793
GeneOntologyCellularComponent	nuclear body	PCNP NOLC1 NPM1 IL16 MAPT SF3A1 NUP98 ZC3H18 DZIP1 EFTUD2 PARP1 BRD2 CCNB3 MDC1 H2AX SMN1 SON	4.54e-05	903	130	17	GO:0016604
GeneOntologyCellularComponent	nuclear speck	NPM1 IL16 MAPT SF3A1 ZC3H18 DZIP1 EFTUD2 BRD2 CCNB3 H2AX SON	8.13e-05	431	130	11	GO:0016607
GeneOntologyCellularComponent	kinetochore	PPP1R12A NUP98 APC CLIP1 CFDP1 DYNC1LI1 DYNC1LI2	1.40e-04	181	130	7	GO:0000776
GeneOntologyCellularComponent	postsynapse	ANK2 ABI3BP MAP4 MAPT HIP1R APC GABBR2 SLC1A7 ADD3 NEFM NEO1 CASKIN1 EIF4G2 RAPGEF2 ADGRL2 NOS1 GABRA2	1.94e-04	1018	130	17	GO:0098794
GeneOntologyCellularComponent	condensed chromosome, centromeric region	PPP1R12A NUP98 APC CLIP1 CFDP1 DYNC1LI1 DYNC1LI2	2.08e-04	193	130	7	GO:0000779
GeneOntologyCellularComponent	postsynaptic specialization	ANK2 ABI3BP MAP4 MAPT HIP1R ADD3 NEFM NEO1 EIF4G2 NOS1 GABRA2	3.11e-04	503	130	11	GO:0099572
GeneOntologyCellularComponent	chromosome, centromeric region	PPP1R12A NUP98 APC CLIP1 CFDP1 SYCP1 DYNC1LI1 DYNC1LI2	3.38e-04	276	130	8	GO:0000775
GeneOntologyCellularComponent	neurofibrillary tangle	MAPT NEFM	3.79e-04	5	130	2	GO:0097418
GeneOntologyCellularComponent	postsynaptic density	ANK2 ABI3BP MAP4 MAPT HIP1R ADD3 NEFM NEO1 EIF4G2 NOS1	5.26e-04	451	130	10	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	ANK2 ABI3BP MAP4 MAPT HIP1R ADD3 NEFM NEO1 EIF4G2 NOS1	8.09e-04	477	130	10	GO:0032279
GeneOntologyCellularComponent	supramolecular fiber	ANK2 MAP4 MAPT PPP1R12A APC NCKAP5 CLIP1 NEFM MTUS1 NAV3 NAV1 DYNC1LI1 LMOD1 SMN1 TXNDC2 NOS1 DYNC1LI2	1.03e-03	1179	130	17	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	ANK2 MAP4 MAPT PPP1R12A APC NCKAP5 CLIP1 NEFM MTUS1 NAV3 NAV1 DYNC1LI1 LMOD1 SMN1 TXNDC2 NOS1 DYNC1LI2	1.11e-03	1187	130	17	GO:0099081
GeneOntologyCellularComponent	granular component	NPM1 CLEC3B	1.34e-03	9	130	2	GO:0001652
GeneOntologyCellularComponent	neuron to neuron synapse	ANK2 ABI3BP MAP4 MAPT HIP1R ADD3 NEFM NEO1 EIF4G2 NOS1	1.61e-03	523	130	10	GO:0098984
GeneOntologyCellularComponent	microtubule end	NCKAP5 CLIP1 NAV3	1.69e-03	38	130	3	GO:1990752
GeneOntologyCellularComponent	microtubule	MAP4 MAPT APC NCKAP5 CLIP1 MTUS1 NAV3 NAV1 DYNC1LI1 DYNC1LI2	1.85e-03	533	130	10	GO:0005874
Domain	Dynein1_light_intermed_chain	DYNC1LI1 DYNC1LI2	4.59e-05	2	127	2	IPR008467
Domain	Dynein_light_int_chain	DYNC1LI1 DYNC1LI2	1.37e-04	3	127	2	IPR022780
Domain	TAU_MAP_2	MAP4 MAPT	1.37e-04	3	127	2	PS51491
Domain	Tubulin-binding	MAP4 MAPT	1.37e-04	3	127	2	PF00418
Domain	MAP_tubulin-bd_rpt	MAP4 MAPT	1.37e-04	3	127	2	IPR001084
Domain	TAU_MAP_1	MAP4 MAPT	1.37e-04	3	127	2	PS00229
Domain	MAP2/MAP4/Tau	MAP4 MAPT	1.37e-04	3	127	2	IPR027324
Domain	DLIC	DYNC1LI1 DYNC1LI2	1.37e-04	3	127	2	PF05783
Domain	P5-ATPase	ATP13A5 ATP13A3	2.73e-04	4	127	2	PF12409
Domain	BRCT	RFC1 PARP1 MDC1	2.75e-04	19	127	3	PF00533
Domain	BRCT	RFC1 PARP1 MDC1	4.30e-04	22	127	3	SM00292
Domain	P-type_TPase_V	ATP13A5 ATP13A3	4.53e-04	5	127	2	IPR006544
Domain	-	RFC1 PARP1 MDC1	4.92e-04	23	127	3	3.40.50.10190
Domain	BRCT	RFC1 PARP1 MDC1	7.12e-04	26	127	3	PS50172
Domain	BRCT_dom	RFC1 PARP1 MDC1	8.88e-04	28	127	3	IPR001357
Domain	KRAB_RELATED	SSX9P SSX7	2.42e-03	11	127	2	PS50806
Domain	PDZ	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	2.78e-03	141	127	5	PF00595
Domain	Krueppel-associated_box-rel	SSX9P SSX7	3.41e-03	13	127	2	IPR003655
Domain	PDZ	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	3.42e-03	148	127	5	SM00228
Domain	-	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	3.63e-03	150	127	5	2.30.42.10
Domain	PDZ	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	3.73e-03	151	127	5	PS50106
Domain	PDZ	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	3.84e-03	152	127	5	IPR001478
Domain	WW	MAGI1 PCIF1 PLEKHA7	4.00e-03	47	127	3	PF00397
Domain	WW	MAGI1 PCIF1 PLEKHA7	4.25e-03	48	127	3	SM00456
Domain	WW_DOMAIN_1	MAGI1 PCIF1 PLEKHA7	5.04e-03	51	127	3	PS01159
Domain	WW_DOMAIN_2	MAGI1 PCIF1 PLEKHA7	5.04e-03	51	127	3	PS50020
Domain	WW_dom	MAGI1 PCIF1 PLEKHA7	5.32e-03	52	127	3	IPR001202
Domain	Cation_ATPase_N	ATP13A5 ATP13A3	6.54e-03	18	127	2	PF00690
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MTA2 PCNP NOLC1 NPM1 MYBBP1A LIMA1 ANK2 MAP4 SF3A1 PPP1R12A NACA NUP98 TNRC6B TACC2 RFC1 GPRIN1 WNK1 DNTTIP2 WDR43 ADD3 EFTUD2 ZNF512B KIAA1671 PARP1 PTPN13 LPP CFDP1 EIF4G2 NUCKS1 LTV1 ZNF598 SON	8.78e-22	934	131	32	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NOLC1 MYBBP1A LIMA1 MYCBP2 MAP4 MAPT SF3A1 NUP98 ZC3H18 REST RFC1 MORC2 GPRIN1 CLIP1 PHC2 EFTUD2 MYOF BRD2 ANLN MDC1 EIF4G2 NUCKS1 DYNC1LI1 DYNC1LI2 SON	1.71e-16	774	131	25	15302935
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MTA2 PCNP MYBBP1A LIMA1 MYCBP2 MAP4 PPP1R12A TNRC6B GPRIN1 UBN2 JMJD1C LUZP1 ADD3 KIAA1671 NEFM PTPN13 ANLN MDC1 LPP PEAK1 ZNF598	2.08e-15	549	131	21	38280479
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PCNP NOLC1 NPM1 ANK2 MYCBP2 MAP4 MAPT NACA HIP1R APC TNRC6B TACC2 CEND1 GABBR2 GPRIN1 ADD3 NEO1 CASKIN1 EIF4G2 NAV3 NAV1 H2AX DYNC1LI1 PEAK1 NOS1 GABRA2	1.37e-13	1139	131	26	36417873
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NOLC1 MAGI1 LIMA1 MYCBP2 MAP4 MAPT PPP1R12A DCP2 APC DZIP1 WNK1 LUZP1 KIAA1671 FSIP2 PTPN13 MTUS1 ANLN LPP NAV1 PEAK1 RAPGEF2 ZNF598 PLEKHA7	1.69e-13	861	131	23	36931259
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MTA2 NOLC1 NPM1 MYBBP1A LIMA1 MAP4 SF3A1 PPP1R12A NACA NUP98 ZC3H18 RFC1 DNTTIP2 LUZP1 WDR43 ADD3 PHC2 EFTUD2 KIAA1671 MYOF PARP1 ANLN MDC1 NAV1 SMN1 LTV1 ZNF598	1.82e-13	1257	131	27	36526897
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	PCNP NOLC1 NPM1 MYBBP1A RBM33 SF3A1 ZC3H18 JMJD1C DNTTIP2 MDC1 NUCKS1 SON	4.61e-13	148	131	12	32538781
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NOLC1 NPM1 MYBBP1A MAP4 RBM33 SF3A1 BCORL1 NUP98 ZC3H18 RFC1 UBN2 JMJD1C DNTTIP2 LUZP1 WDR43 EFTUD2 ZNF512B PARP1 BRD2 ANLN MDC1 EIF4G2 SON	1.38e-12	954	131	23	36373674
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	NOLC1 NPM1 MYBBP1A LIMA1 PPP1R12A NACA NUP98 ZC3H18 DNTTIP2 LUZP1 WDR43 EFTUD2 KIAA1671 MYOF PARP1 BRD2 ANLN MDC1 H2AX	7.30e-12	660	131	19	32780723
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MTA2 NOLC1 NPM1 MYBBP1A SF3A1 BCORL1 NUP98 ZC3H18 REST RFC1 UBN2 JMJD1C DNTTIP2 WDR43 PHC2 EFTUD2 ZNF512B PCGF6 PARP1 BRD2 MDC1 EIF4G2 ASXL2 TET3 SON	1.60e-11	1294	131	25	30804502
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	PCNP MYBBP1A LIMA1 MAP4 NACA NUP98 APC JMJD1C LUZP1 MYOF ANLN EIF4G2 NUCKS1	1.84e-11	256	131	13	33397691
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	RC3H2 KIAA0586 APC TNRC6B LUZP1 ADD3 KIAA1671 PTPN13 MTUS1 LPP LTV1 PEAK1	2.74e-11	209	131	12	36779422
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	NPM1 MYBBP1A LIMA1 MAP4 NUP98 RFC1 MORC2 CLIP1 WDR43 DYNC1LI1 SMN1 SON	2.90e-11	210	131	12	16565220
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MTA2 PCNP NOLC1 NPM1 MYBBP1A LIMA1 MAP4 SF3A1 NACA NUP98 HIP1R ZC3H18 RFC1 GPRIN1 WNK1 EFTUD2 MYOF PARP1 MTUS1 ANLN LPP CFDP1 EIF4G2 NUCKS1 SON	5.11e-11	1367	131	25	32687490
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MTA2 PCNP NPM1 RC3H2 MYBBP1A FN1 ANK2 MAP4 SF3A1 DCP2 NACA TNRC6B RFC1 MORC2 CLIP1 LUZP1 WDR43 ADD3 PHC2 PARP1 AHR SMN1 LTV1 SON MAJIN	5.44e-11	1371	131	25	36244648
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PCNP MAP4 RBM33 PPP1R12A NACA HIP1R APC CD55 TNRC6B MORC2 UBN2 LUZP1 WDR43 PHC2 KIAA1671 MYOF PTPN13 BRD2 ANLN MDC1 EIF4G2 CXXC4 SMN1 ZNF598 PLEKHA7 SON	6.10e-11	1497	131	26	31527615
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	PCNP MYBBP1A MAP4 RBM33 SF3A1 ZC3H18 RFC1 JMJD1C DNTTIP2 WDR43 PARP1 MDC1 CFDP1	6.43e-11	283	131	13	30585729
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	NOLC1 NPM1 MYBBP1A GGA2 FN1 NUP98 APC TNRC6B GPRIN1 ADD3 EFTUD2 KIAA1671 PPP2R3A NEO1 PTPN13 PEAK1 RAPGEF2 ADGRL2 DYNC1LI2	1.17e-10	777	131	19	35844135
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PCNP NOLC1 MYBBP1A FN1 MAP4 PPP1R12A APC CD55 TACC2 UBN2 WNK1 DNTTIP2 PTPN13 ANLN LPP EIF4G2 ASXL2 PEAK1 HERC1 PLEKHA7 DYNC1LI2 UTP14C	1.22e-10	1084	131	22	11544199
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MTA2 PCNP LIMA1 MAP4 TNRC6B TACC2 UBN2 JMJD1C DNTTIP2 LUZP1 ADD3 PARP1 ANLN LPP EIF4G2	1.53e-10	444	131	15	34795231
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MTA2 BCORL1 ZC3H18 RFC1 MORC2 UBN2 JMJD1C DNTTIP2 WDR43 ZNF512B FSIP2 PCGF6 PARP1 BRD2 ANLN MDC1 CFDP1	1.58e-10	608	131	17	36089195
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	LIMA1 GGA2 MYCBP2 MAPT RBM33 NACA NUP98 TNRC6B GPRIN1 DNTTIP2 LUZP1 PHC2 EFTUD2 KIAA1671 PTPN13 LPP EIF4G2 NUCKS1 LTV1 PEAK1 ZNF598	2.08e-10	1007	131	21	34597346
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PCNP RC3H2 MYCBP2 MAP4 MAPT RBM33 PPP1R12A APC TNRC6B MORC2 UBN2 LUZP1 PCGF6 MYOF PTPN13 H2AX ZNF598 SON	2.90e-10	724	131	18	36232890
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MTA2 NOLC1 NPM1 MYBBP1A FN1 MYCBP2 MAP4 SF3A1 NUP98 ZC3H18 RFC1 DNTTIP2 WDR43 NEFM MDC1 H2AX SON	4.69e-10	653	131	17	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NPM1 MAGI1 MYBBP1A LIMA1 ANK2 MYCBP2 PPP1R12A APC TNRC6B GABBR2 UBN2 CLIP1 LUZP1 EFTUD2 NEFM PARP1 CASKIN1 NAV1 RAPGEF2 NOS1	6.29e-10	963	131	20	28671696
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NOLC1 MYBBP1A MAP4 NUP98 APC TACC2 RFC1 MORC2 WNK1 CLIP1 WDR43 ANLN NUCKS1 DYNC1LI2 SON	8.47e-10	503	131	15	16964243
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MAGI1 FN1 PPP1R12A APC KIAA1549 STOX1 GABBR2 LUZP1 ADD3 NEFM PTPN13 CASKIN1 DYNC1LI1 RAPGEF2	1.04e-09	430	131	14	32581705
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	MAP4 NUP98 TNRC6B ATP13A5 CCDC168 JMJD1C FSIP2 MDC1 EIF4G2	1.06e-09	123	131	9	26912792
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MTA2 NOLC1 NPM1 IL16 MAPT PPP1R12A KIAA1549 TNRC6B ZC3H18 DNTTIP2 LUZP1 ZNF512B KIAA1671 BRD2 MTUS1 CCNB3 AHR H2AX RAPGEF2 ADGRL2 SON	1.31e-09	1116	131	21	31753913
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYBBP1A LIMA1 PPP1R12A RFC1 EFTUD2 PARP1 MDC1 SYCP1 LTV1 HERC1 UTP14C	1.58e-09	234	131	11	36243803
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	NPM1 MAGI1 MYBBP1A ANK2 MAP4 SF3A1 APC TNRC6B ZC3H18 GPRIN1 JMJD1C PARP1 PTPN13 EIF4G2 LTV1 PEAK1 ADGRL2	1.59e-09	708	131	17	39231216
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYBBP1A MYCBP2 NUP98 KIAA1549 GPRIN1 LUZP1 FAN1 ZNF512B KIAA1671 PARP1 PPP2R3A PTPN13 BRD2 MTUS1 LPP NUCKS1 PEAK1 HERC1 ADGRL2 PLEKHA7	2.71e-09	1049	131	20	27880917
Pubmed	Human transcription factor protein interaction networks.	NOLC1 MYBBP1A LIMA1 RBM33 NACA BCORL1 NUP98 TNRC6B ZC3H18 RFC1 MORC2 UBN2 JMJD1C ZNF512B KIAA1671 PCGF6 BRD2 MDC1 CFDP1 SMN1 LTV1 ASXL2 HERC1	3.85e-09	1429	131	23	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MTA2 NPM1 MYBBP1A LIMA1 IL16 FN1 ANK2 MAP4 MAPT PPP1R12A APC KIAA1549 LUZP1 ADD3 NEFM PARP1 CASKIN1 EIF4G2 NAV1 PEAK1 RAPGEF2 PLEKHA7 NOS1	3.95e-09	1431	131	23	37142655
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 LIMA1 MAP4 GPRIN1 LUZP1 ADD3 KIAA1671 ANLN LPP EIF4G2 VSIG10L PEAK1 ADGRL2 PLEKHA7 IL6ST	4.08e-09	565	131	15	25468996
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	MTA2 LIMA1 RBM33 SF3A1 PPP1R12A WNK1 FSIP2 PARP1 BRD2 MDC1 DYNC1LI1 DYNC1LI2 SON	4.20e-09	399	131	13	35987950
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MTA2 NOLC1 NPM1 MYBBP1A MYCBP2 SF3A1 APC TNRC6B ZC3H18 PHC2 EFTUD2 ZNF512B NEFM PARP1 PTPN13 BRD2 NUCKS1 DYNC1LI1 DYNC1LI2 SON	4.57e-09	1082	131	20	38697112
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	FN1 ANK2 MYCBP2 DZIP1 WNK1 CLIP1 JMJD1C DNTTIP2 PCGF6 NEO1 EIF4G2 NUCKS1 IL6ST SON	6.58e-09	497	131	14	23414517
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MTA2 NOLC1 NPM1 MYBBP1A LIMA1 MYCBP2 MAP4 SF3A1 NACA NUP98 DNTTIP2 WDR43 EFTUD2 ZNF512B KIAA1671 PARP1 BRD2 MDC1 SON	1.09e-08	1024	131	19	24711643
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NOLC1 MYBBP1A SF3A1 PPP1R12A DCP2 NACA NUP98 APC TACC2 CLIP1 WDR43 EFTUD2 CEP120 HP ANLN SYCP1 DYNC1LI1 LTV1 ASXL2 DYNC1LI2	1.36e-08	1155	131	20	20360068
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	LIMA1 MYCBP2 PPP1R12A APC ZC3H18 EFTUD2 KIAA1671 MTUS1 ANLN NAV1 PEAK1 SON	1.37e-08	361	131	12	30344098
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MAGI1 LIMA1 APC KIAA1549 TNRC6B WNK1 CLIP1 LUZP1 KIAA1671 PTPN13 NAV1 RAPGEF2 PLEKHA7	1.57e-08	446	131	13	24255178
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MTA2 NOLC1 MAGI1 MYBBP1A LIMA1 MYCBP2 SF3A1 PPP1R12A WNK1 CLIP1 LUZP1 EFTUD2 KIAA1671 NEFM PTPN13 CEP120 NAV1 DYNC1LI1 LTV1 PLEKHA7 DYNC1LI2	2.47e-08	1321	131	21	27173435
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MTA2 NOLC1 NPM1 MYBBP1A FN1 MYCBP2 MAP4 NACA HIP1R RFC1 DNTTIP2 LUZP1 EFTUD2 PCGF6 PARP1 ANLN MDC1 EIF4G2 DYNC1LI1 LTV1 SON	3.71e-08	1353	131	21	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NOLC1 NPM1 MYBBP1A ANK2 MYCBP2 SF3A1 KIAA1549 DZIP1 GPRIN1 DNTTIP2 ADD3 EFTUD2 ZNF512B PCGF6 PARP1 NEO1 PTPN13 BRD2 EIF4G2 LTV1 PEAK1 ADGRL2	3.92e-08	1487	131	22	33957083
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	NOLC1 NPM1 MAGI1 MYBBP1A LIMA1 MAP4 SF3A1 PPP1R12A NUP98 APC TNRC6B RFC1 LUZP1 EFTUD2 MYOF PARP1 EIF4G2 AHR ZNF598 DYNC1LI2	4.78e-08	1247	131	20	27684187
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RBM33 APC KIAA1549 TNRC6B JMJD1C KIAA1671 PTPN13 LPP PEAK1 PLEKHA7	6.66e-08	263	131	10	34702444
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	MTA2 NOLC1 NPM1 LIMA1 RBM33 SF3A1 LUZP1 ADD3 ANLN MDC1 CFDP1 NUCKS1 SON	6.85e-08	506	131	13	30890647
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	NPM1 MYBBP1A FN1 MYCBP2 MAP4 RBM33 SF3A1 PPP1R12A NACA APC RFC1 EFTUD2 PARP1 EIF4G2 DYNC1LI1 SMN1	7.30e-08	809	131	16	32129710
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	NPM1 LIMA1 MAP4 SF3A1 PPP1R12A RFC1 EFTUD2 MYOF PARP1 MDC1 ZNF598	7.41e-08	340	131	11	24332808
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	NPM1 MYBBP1A LIMA1 ANK2 SF3A1 RFC1 EFTUD2 PARP1 ANLN MDC1	8.81e-08	271	131	10	32433965
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 NOLC1 NPM1 MYBBP1A MAP4 SF3A1 KIAA0586 NACA NUP98 RFC1 DNTTIP2 WDR43 EFTUD2 PARP1 MDC1 EIF4G2 NUCKS1 DYNC1LI1 LTV1 PEAK1 PLEKHA7	8.87e-08	1425	131	21	30948266
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	MAGI1 MYBBP1A LIMA1 MAP4 PPP1R12A LUZP1 EFTUD2 NEFM PARP1 PLEKHA7	9.76e-08	274	131	10	34244482
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NOLC1 NPM1 MYBBP1A LIMA1 ANK2 ABI3BP PPP1R12A FAM178B NUP98 CEND1 STOX1 TRDN SLC4A3 DNTTIP2 LUZP1 NEFM PARP1 BRD2 SYCP1 H2AX UTP14C	1.08e-07	1442	131	21	35575683
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	MTA2 NOLC1 NPM1 MYBBP1A LIMA1 MYCBP2 SF3A1 PPP1R12A JMJD1C KIAA1671 PARP1 EIF4G2 ZNF598 SON	1.11e-07	624	131	14	33729478
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	MTA2 NOLC1 NPM1 MYBBP1A LIMA1 MAP4 SF3A1 PPP1R12A NACA CD55 DNTTIP2 LUZP1 WDR43 EFTUD2 PARP1 MDC1 SON	1.14e-07	949	131	17	36574265
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NOLC1 GGA2 NACA HIP1R KIAA1549 DZIP1 WDR43 ZNF512B MTUS1 CASKIN1 MDC1 PCNX1 ADGRL2	1.14e-07	529	131	13	14621295
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MYCBP2 RBM33 NACA APC TNRC6B WNK1 JMJD1C NEO1 ANLN MDC1 LPP NAV1 NUCKS1 DYNC1LI1 DYNC1LI2	1.24e-07	733	131	15	34672954
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MTA2 NPM1 MYBBP1A LIMA1 SF3A1 PPP1R12A NUP98 ZC3H18 RFC1 DNTTIP2 LUZP1 EFTUD2 ZNF512B MDC1 SMN1 SON	1.36e-07	847	131	16	35850772
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GGA2 APC TNRC6B CLIP1 LUZP1 KIAA1671 PPP2R3A CEP120 MTUS1 CAPN7 EIF4G2 DYNC1LI1 LTV1 ZNF598 PLEKHA7 DYNC1LI2	1.49e-07	853	131	16	28718761
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MYCBP2 PPP1R12A BCORL1 TNRC6B RFC1 MORC2 UBN2 WNK1 LUZP1 PHC2 ZNF512B BRD2 ANLN NAV1	1.65e-07	645	131	14	25281560
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MTA2 PCNP NOLC1 MYCBP2 MAP4 RBM33 SF3A1 BCORL1 RFC1 MORC2 UBN2 JMJD1C PARP1 ANLN EIF4G2 NUCKS1 DYNC1LI1 ASXL2	1.86e-07	1103	131	18	34189442
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	MTA2 NOLC1 NPM1 MYBBP1A FN1 SF3A1 NACA EFTUD2 NEFM PARP1 HP MDC1 H2AX SON	1.88e-07	652	131	14	31180492
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	NPM1 MYBBP1A FN1 NUP98 ADD3 EFTUD2 MYOF PARP1 AHR	2.10e-07	226	131	9	37839992
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	LIMA1 ANK2 MAP4 PPP1R12A GPRIN1 NEFM	2.10e-07	67	131	6	29254152
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PCNP NOLC1 RC3H2 MYBBP1A NUP98 ZC3H18 REST RFC1 LUZP1 WDR43 BRD2 HYDIN	2.34e-07	469	131	12	27634302
Pubmed	Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.	DNTTIP2 ZNF512B PARP1 BRD2 MDC1	2.78e-07	37	131	5	36835656
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MTA2 PCNP NOLC1 MYBBP1A MAP4 NUP98 ZC3H18 RFC1 MORC2 PHC2 PARP1 BRD2 MDC1 CFDP1 EIF4G2 NUCKS1 SON	2.89e-07	1014	131	17	32416067
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	PCNP NPM1 ZNF512B PARP1 MDC1 NUCKS1	3.24e-07	72	131	6	31248990
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MTA2 NPM1 MYBBP1A LIMA1 MYCBP2 MAP4 SF3A1 PPP1R12A NACA RFC1 LUZP1 EFTUD2 NEFM PARP1 NUCKS1 DYNC1LI1 SMN1 DYNC1LI2	3.38e-07	1149	131	18	35446349
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	NOLC1 NPM1 MYBBP1A MAP4 SF3A1 NACA TNRC6B TACC2 ZC3H18 RFC1 WNK1 DNTTIP2 EFTUD2 PARP1 MDC1 LPP EIF4G2 NAV1 LTV1 SON	3.61e-07	1415	131	20	28515276
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	NOLC1 NPM1 RC3H2 MYBBP1A MAP4 RBM33 SF3A1 ZC3H18 DNTTIP2 EFTUD2 PARP1 EIF4G2 NUCKS1 ZNF598 SON	4.22e-07	807	131	15	22681889
Pubmed	Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).	NOLC1 NPM1 FN1 ABI3BP MAP4 EFTUD2 RASGRP1 NUCKS1 H2AX	4.42e-07	247	131	9	39238192
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	PCNP NPM1 MYBBP1A MAP4 MAPT GPRIN1 NEFM PARP1 NAV1 H2AX DYNC1LI1 DYNC1LI2	4.43e-07	498	131	12	36634849
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	MTA2 NOLC1 NPM1 MYBBP1A SF3A1 ZC3H18 RFC1 EFTUD2 ZNF512B PARP1 BRD2 MDC1 EIF4G2	5.24e-07	605	131	13	28977666
Pubmed	MORC2B is essential for meiotic progression and fertility.	MORC2 CCNB3 SYCP1 H2AX	5.65e-07	18	131	4	29329290
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	PCNP MYBBP1A BCORL1 JMJD1C DNTTIP2 WDR43 EFTUD2 PCGF6 BRD2 ANLN	6.90e-07	339	131	10	30415952
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	MTA2 PCNP NPM1 LIMA1 SF3A1 NACA WNK1 CLIP1 EFTUD2 NEFM PARP1 NUCKS1 DYNC1LI1 LTV1 DYNC1LI2	7.73e-07	847	131	15	35235311
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	MTA2 NPM1 MYBBP1A ANK2 MAP4 SF3A1 NACA TNRC6B ZC3H18 RFC1 EFTUD2 PARP1 EIF4G2 H2AX LTV1 UTP14C	8.33e-07	971	131	16	33306668
Pubmed	MORC2 regulates DNA damage response through a PARP1-dependent pathway.	MORC2 PARP1 H2AX	1.04e-06	6	131	3	31616951
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MTA2 NOLC1 NPM1 MYBBP1A SF3A1 RFC1 JMJD1C DNTTIP2 WDR43 PHC2 EFTUD2 PARP1 BRD2 ANLN MDC1 SON	1.06e-06	989	131	16	36424410
Pubmed	A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.	MYBBP1A MYCBP2 PTPN13 SMN1	1.09e-06	21	131	4	24923560
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	PCNP NPM1 MYBBP1A LIMA1 MAP4 SF3A1 NACA EFTUD2 NEFM PARP1 ANLN ZNF598	1.28e-06	551	131	12	34728620
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MYBBP1A FN1 TSHZ2 RBM33 TNRC6B NCKAP5 WNK1 EFTUD2 MYOF EIF4G2	1.28e-06	363	131	10	14691545
Pubmed	RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.	NOLC1 PPP1R12A LUZP1 EFTUD2 PARP1	1.30e-06	50	131	5	30413534
Pubmed	The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development.	MTA2 MYBBP1A REST PCGF6 PARP1	1.44e-06	51	131	5	22770845
Pubmed	The functional interactome landscape of the human histone deacetylase family.	MTA2 MYCBP2 SF3A1 NUP98 DNTTIP2 ADD3 ZNF512B SMN1 SON	1.63e-06	289	131	9	23752268
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAGI1 ANK2 SLITRK4 KIAA1549 ADD3 NEO1 NAV1 ATP13A3 PEAK1 PLEKHA7 MYRF IL6ST	1.78e-06	569	131	12	30639242
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	GGA2 TNRC6B LUZP1 CEP120 LPP PEAK1 ZNF598 NYAP1	1.87e-06	218	131	8	33378226
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	MTA2 RBM33 PPP1R12A NACA HIP1R TNRC6B CLIP1 ANLN NUCKS1 DYNC1LI1 DYNC1LI2	1.88e-06	472	131	11	38943005
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MTA2 NPM1 LIMA1 SF3A1 PPP1R12A NACA CD55 LUZP1 EFTUD2 PARP1 SON	2.09e-06	477	131	11	31300519
Pubmed	BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.	NCKAP5 F8 DYNC1LI1 DYNC1LI2 UTP14C	2.51e-06	57	131	5	27433848
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	MTA2 MYBBP1A ZC3H18 RFC1 PHC2 PARP1 BRD2 MDC1 H2AX DYNC1LI1	2.66e-06	394	131	10	27248496
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	NPM1 MAPT GPRIN1 LUZP1 NEFM CASKIN1 DYNC1LI1 PEAK1	2.88e-06	231	131	8	16452087
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	CFAP47 NOLC1 NPM1 MYBBP1A MAP4 SF3A1 NACA TNRC6B CLIP1 EFTUD2 PARP1	2.92e-06	494	131	11	26831064
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	MTA2 RC3H2 MYCBP2 BCORL1 PHC2 ZNF512B PCGF6 BRD2 MTUS1 LTV1 ASXL2	2.97e-06	495	131	11	27705803
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	MTA2 SF3A1 EFTUD2 MYOF PARP1 PTPN13 ANLN EIF4G2 AHR H2AX	3.04e-06	400	131	10	35013556
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	MYCBP2 NACA BCORL1 APC TNRC6B JMJD1C PCGF6 LTV1	4.06e-06	242	131	8	34011540
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	NOLC1 NPM1 MYBBP1A MAP4 SF3A1 NACA HIP1R ZC3H18 WDR43 EFTUD2 PARP1 H2AX SON	4.21e-06	731	131	13	29298432
Pubmed	Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation.	SYCP1 H2AX MAJIN	4.31e-06	9	131	3	28031483
Interaction	NAA40 interactions	MTA2 PCNP NOLC1 NPM1 MYBBP1A LIMA1 ANK2 MAP4 SF3A1 PPP1R12A NACA NUP98 TNRC6B TACC2 RFC1 GPRIN1 WNK1 DNTTIP2 WDR43 ADD3 EFTUD2 ZNF512B KIAA1671 PARP1 PTPN13 LPP CFDP1 EIF4G2 NUCKS1 LTV1 ZNF598 SON	1.87e-14	978	131	32	int:NAA40
Interaction	YWHAZ interactions	NOLC1 NPM1 LIMA1 FN1 MYCBP2 MAPT PPP1R12A HIP1R APC TACC2 ZC3H18 DZIP1 WNK1 CLIP1 LUZP1 FAN1 EFTUD2 KIAA1671 NEFM FSIP2 PTPN13 MTUS1 ANLN MDC1 NAV1 H2AX DYNC1LI1 ASXL2 PEAK1 RAPGEF2 ZNF598 PLEKHA7 NOS1	1.13e-11	1319	131	33	int:YWHAZ
Interaction	NUP43 interactions	MTA2 NPM1 MAP4 PPP1R12A NUP98 APC TNRC6B ATP13A5 ZC3H18 CCDC168 RFC1 MORC2 UBN2 JMJD1C DNTTIP2 WDR43 FSIP2 MDC1 EIF4G2 ASXL2 RAPGEF2 SON	9.98e-11	625	131	22	int:NUP43
Interaction	CBX3 interactions	NPM1 FN1 MAPT PPP1R12A BCORL1 REST RFC1 MORC2 UBN2 DNTTIP2 WDR43 EFTUD2 ZNF512B PCGF6 PARP1 BRD2 ANLN MDC1 CFDP1 NUCKS1 H2AX ASXL2	1.87e-10	646	131	22	int:CBX3
Interaction	WWTR1 interactions	MTA2 MYBBP1A LIMA1 IL16 MYCBP2 PPP1R12A TNRC6B GPRIN1 JMJD1C LUZP1 ADD3 KIAA1671 NEFM PTPN13 ANLN LPP PEAK1 ZNF598	2.84e-10	422	131	18	int:WWTR1
Interaction	H3C1 interactions	MTA2 NPM1 MYBBP1A ANK2 MAPT NACA RFC1 MORC2 GPRIN1 UBN2 JMJD1C DNTTIP2 EFTUD2 ZNF512B PCGF6 PARP1 BRD2 CCNB3 ANLN MDC1 CFDP1 NAV3 NUCKS1 H2AX LTV1	6.81e-10	901	131	25	int:H3C1
Interaction	MAPRE1 interactions	LIMA1 FN1 MAPT PPP1R12A NUP98 APC TACC2 CLIP1 LUZP1 ADD3 NEFM MTUS1 LPP EIF4G2 NAV3 NAV1 DYNC1LI1 ZNF598 DYNC1LI2	9.60e-10	514	131	19	int:MAPRE1
Interaction	YWHAE interactions	MTA2 NOLC1 NPM1 RC3H2 LIMA1 FN1 MYCBP2 MAPT PPP1R12A APC TACC2 ZC3H18 WNK1 CLIP1 LUZP1 FAN1 EFTUD2 KIAA1671 PTPN13 ANLN CAPN7 NAV1 H2AX DYNC1LI1 ASXL2 PEAK1 RAPGEF2 ZNF598 PLEKHA7	1.68e-09	1256	131	29	int:YWHAE
Interaction	CSNK2A1 interactions	MTA2 NOLC1 NPM1 IL16 FN1 MAPT RBM33 SF3A1 NACA NUP98 APC ZC3H18 MORC2 PHC2 EFTUD2 PCGF6 BRD2 ANLN MDC1 CFDP1 EIF4G2 NUCKS1 H2AX LTV1 ASXL2	2.29e-09	956	131	25	int:CSNK2A1
Interaction	NPM1 interactions	NPM1 RC3H2 MYBBP1A GGA2 FN1 MAPT PPP1R12A BCORL1 NUP98 HEMGN ZC3H18 DZIP1 REST RFC1 TRDN DNTTIP2 WDR43 EFTUD2 PARP1 ANLN CASKIN1 EIF4G2 SYCP1 H2AX LMOD1 SMN1 ASXL2 SON	2.74e-09	1201	131	28	int:NPM1
Interaction	KIF20A interactions	NOLC1 NPM1 MYBBP1A LIMA1 ANK2 PPP1R12A LCA5L NUP98 CD55 TNRC6B ZC3H18 MORC2 LUZP1 WDR43 EFTUD2 KIAA1671 NEFM PARP1 ANLN MDC1 NAV3 NUCKS1 H2AX HERC1 TET3 SON	3.38e-09	1052	131	26	int:KIF20A
Interaction	GIGYF2 interactions	MTA2 MAGI1 RC3H2 LIMA1 APC TNRC6B EFTUD2 PTPN13 ANLN NAV1 SMN1 ZNF598 PLEKHA7	1.75e-08	263	131	13	int:GIGYF2
Interaction	DCTN1 interactions	MTA2 MYCBP2 MAP4 MAPT NACA APC CLIP1 LUZP1 EFTUD2 ZNF512B MTUS1 CFDP1 NAV1 DYNC1LI1 LTV1 ZNF598 DYNC1LI2	2.47e-08	497	131	17	int:DCTN1
Interaction	SMC5 interactions	NOLC1 NPM1 MYBBP1A MAP4 RBM33 SF3A1 BCORL1 NUP98 ZC3H18 RFC1 UBN2 JMJD1C DNTTIP2 LUZP1 WDR43 EFTUD2 ZNF512B PARP1 BRD2 ANLN MDC1 EIF4G2 SMN1 SON	2.62e-08	1000	131	24	int:SMC5
Interaction	XRCC6 interactions	MTA2 PCNP NPM1 RC3H2 MYBBP1A FN1 MAP4 RBM33 SF3A1 ZC3H18 RFC1 JMJD1C DNTTIP2 WDR43 EFTUD2 ZNF512B PARP1 ANLN MDC1 CFDP1 H2AX DYNC1LI1 ASXL2	2.97e-08	928	131	23	int:XRCC6
Interaction	FBL interactions	MTA2 NOLC1 NPM1 RC3H2 MYBBP1A FN1 BCORL1 HEMGN ZC3H18 REST RFC1 DNTTIP2 WDR43 EFTUD2 ZNF512B MTUS1 ANLN SMN1 LTV1	3.27e-08	639	131	19	int:FBL
Interaction	HDAC2 interactions	MTA2 NPM1 MYBBP1A LIMA1 MYCBP2 MAP4 PPP1R12A CD55 ZC3H18 REST WNK1 JMJD1C PHC2 EFTUD2 ZNF512B PCGF6 PARP1 LPP EIF4G2 H2AX SMN1 ZNF598	3.93e-08	865	131	22	int:HDAC2
Interaction	GSK3B interactions	RC3H2 MAP4 MAPT RBM33 KIAA0586 NACA APC TNRC6B LUZP1 ADD3 EFTUD2 KIAA1671 MYOF PARP1 PTPN13 MTUS1 HP LPP CLEC3B LTV1 PEAK1 ZNF598	4.17e-08	868	131	22	int:GSK3B
Interaction	HDAC1 interactions	MTA2 NOLC1 NPM1 MYBBP1A FN1 MYCBP2 SF3A1 NUP98 APC TNRC6B REST RFC1 JMJD1C LUZP1 EFTUD2 ZNF512B KIAA1671 NEFM PCGF6 PARP1 PTPN13 ANLN NAV1 NUCKS1 SMN1	4.28e-08	1108	131	25	int:HDAC1
Interaction	KCNA3 interactions	NPM1 MAGI1 MYBBP1A IL16 ANK2 MAP4 SF3A1 NACA APC TNRC6B ZC3H18 MORC2 GPRIN1 CLIP1 JMJD1C LUZP1 PARP1 PTPN13 EIF4G2 LTV1 PEAK1 ADGRL2	4.43e-08	871	131	22	int:KCNA3
Interaction	RPS7 interactions	NOLC1 NPM1 RC3H2 FN1 MAPT NACA APC ZC3H18 REST RFC1 GPRIN1 EFTUD2 ANLN DYNC1LI1 ASXL2 DYNC1LI2	6.25e-08	466	131	16	int:RPS7
Interaction	PRC1 interactions	NOLC1 NPM1 MYBBP1A LIMA1 SF3A1 PPP1R12A NACA NUP98 APC TACC2 ZC3H18 DNTTIP2 LUZP1 WDR43 EFTUD2 KIAA1671 BRD2 ANLN MDC1 H2AX HERC1 SON UTP14C	7.02e-08	973	131	23	int:PRC1
Interaction	PARP1 interactions	MTA2 NOLC1 NPM1 MAGI1 FN1 MYCBP2 MAPT SF3A1 BCORL1 ZC3H18 REST RFC1 MORC2 DNTTIP2 WDR43 EFTUD2 ZNF512B MYOF PARP1 PTPN13 BRD2 ANLN EIF4G2 AHR NUCKS1 H2AX ASXL2	7.95e-08	1316	131	27	int:PARP1
Interaction	SNRPD2 interactions	PCNP NPM1 RC3H2 FN1 MAP4 MAPT SF3A1 ZC3H18 EFTUD2 NEFM PARP1 BRD2 ANLN SMN1 ASXL2	8.30e-08	414	131	15	int:SNRPD2
Interaction	NUPR1 interactions	NOLC1 NPM1 MYBBP1A LIMA1 PPP1R12A NACA NUP98 ZC3H18 DNTTIP2 LUZP1 WDR43 EFTUD2 KIAA1671 MYOF PARP1 BRD2 ANLN MDC1 H2AX	9.30e-08	683	131	19	int:NUPR1
Interaction	BAG2 interactions	NPM1 RC3H2 FN1 MAPT RBM33 SF3A1 PPP1R12A BCORL1 UBN2 WNK1 LUZP1 EFTUD2 KIAA1671 BRD2 ANLN MDC1 EIF4G2 ZNF598	1.17e-07	622	131	18	int:BAG2
Interaction	CAPZA2 interactions	RC3H2 LIMA1 MAPT PPP1R12A HIP1R CLIP1 LUZP1 ADD3 EFTUD2 KIAA1671 PARP1 ANLN H2AX DYNC1LI1 ASXL2	1.36e-07	430	131	15	int:CAPZA2
Interaction	TUBB4B interactions	RC3H2 FN1 MYCBP2 MAPT PPP1R12A APC TACC2 REST MORC2 GPRIN1 CLIP1 EFTUD2 ANLN DYNC1LI1 ASXL2 ZNF598 DYNC1LI2	1.38e-07	560	131	17	int:TUBB4B
Interaction	SUZ12 interactions	MTA2 NOLC1 NPM1 RC3H2 MYBBP1A LIMA1 SF3A1 ZC3H18 REST EFTUD2 ZNF512B PARP1 BRD2 LPP NUCKS1 H2AX ASXL2 SON	1.95e-07	644	131	18	int:SUZ12
Interaction	CSNK2A2 interactions	MTA2 NOLC1 NPM1 IL16 SF3A1 NACA BCORL1 ZC3H18 PHC2 EFTUD2 PCGF6 PARP1 BRD2 ANLN CFDP1 EIF4G2 NUCKS1 LTV1 DYNC1LI2	2.01e-07	718	131	19	int:CSNK2A2
Interaction	ZYX interactions	NPM1 FN1 ANK2 KIAA0586 APC TNRC6B WNK1 LUZP1 ZNF512B KIAA1671 LPP PEAK1 ZNF598	2.38e-07	329	131	13	int:ZYX
Interaction	PHLPP1 interactions	PCNP MYBBP1A LIMA1 MAP4 NACA NUP98 APC JMJD1C LUZP1 MYOF ANLN EIF4G2 NUCKS1	2.74e-07	333	131	13	int:PHLPP1
Interaction	NSD2 interactions	PCNP NPM1 MYBBP1A MYCBP2 ZNF512B PARP1 PTPN13 BRD2 HP MDC1 NUCKS1 SMN1	2.77e-07	278	131	12	int:NSD2
Interaction	MAPRE3 interactions	MAP4 MAPT APC NCKAP5 TACC2 CLIP1 LUZP1 KIAA1671 MTUS1 NAV1 ZNF598	3.22e-07	230	131	11	int:MAPRE3
Interaction	RYBP interactions	MYBBP1A ANK2 PPP1R12A BCORL1 F8 LUZP1 PHC2 PCGF6 MYOF PARP1 BRD2	3.51e-07	232	131	11	int:RYBP
Interaction	GSK3A interactions	RC3H2 MAPT SF3A1 KIAA0586 APC TNRC6B LUZP1 ADD3 KIAA1671 PARP1 PTPN13 MTUS1 LPP LTV1 PEAK1	3.59e-07	464	131	15	int:GSK3A
Interaction	ATG16L1 interactions	MTA2 PCNP MYBBP1A LIMA1 GGA2 MYCBP2 MAP4 MAPT RBM33 PPP1R12A KIAA0586 APC CCDC168 MYOF PARP1 PPP2R3A PTPN13 ANLN EIF4G2 NAV1 H2AX LTV1 HERC1 MYRF	4.15e-07	1161	131	24	int:ATG16L1
Interaction	G3BP1 interactions	MTA2 NOLC1 NPM1 RC3H2 MYBBP1A FN1 MYCBP2 MAP4 MAPT NUP98 TNRC6B ZC3H18 CLIP1 LUZP1 ADD3 EFTUD2 ANLN LPP EIF4G2 LTV1	4.55e-07	835	131	20	int:G3BP1
Interaction	SFN interactions	NOLC1 MAGI1 LIMA1 MYCBP2 MAP4 MAPT PPP1R12A APC ZC3H18 WNK1 LUZP1 KIAA1671 PTPN13 MTUS1 ANLN NAV1 PEAK1 PLEKHA7	5.58e-07	692	131	18	int:SFN
Interaction	YWHAB interactions	MAGI1 RC3H2 LIMA1 FN1 MYCBP2 MAPT PPP1R12A APC DZIP1 WNK1 LUZP1 EFTUD2 KIAA1671 PTPN13 ANLN NAV1 H2AX DYNC1LI1 PEAK1 RAPGEF2 PLEKHA7 SON	6.06e-07	1014	131	22	int:YWHAB
Interaction	EZR interactions	NOLC1 LIMA1 FN1 ANK2 MAPT APC KIAA1549 GPRIN1 LUZP1 ADD3 EFTUD2 KIAA1671 ANLN LPP DYNC1LI1 PEAK1	6.27e-07	553	131	16	int:EZR
Interaction	POLR1G interactions	MTA2 NOLC1 NPM1 RC3H2 MYBBP1A BCORL1 ZC3H18 RFC1 MORC2 UBN2 DNTTIP2 WDR43 ZNF512B BRD2 CFDP1	6.96e-07	489	131	15	int:POLR1G
Interaction	EMG1 interactions	NPM1 FN1 ZC3H18 EFTUD2 PARP1 ANLN EIF4G2 AHR	7.42e-07	113	131	8	int:EMG1
Interaction	SMARCB1 interactions	MTA2 IL16 SF3A1 PPP1R12A APC TACC2 EFTUD2 PARP1 BRD2 MDC1 NUCKS1 H2AX SON	7.49e-07	364	131	13	int:SMARCB1
Interaction	H3C3 interactions	MTA2 BCORL1 ZC3H18 RFC1 MORC2 JMJD1C DNTTIP2 WDR43 ZNF512B FSIP2 PCGF6 PARP1 BRD2 ANLN MDC1	8.11e-07	495	131	15	int:H3C3
Interaction	YWHAQ interactions	NOLC1 NPM1 LIMA1 FN1 MYCBP2 MAP4 MAPT PPP1R12A APC DZIP1 RFC1 WNK1 LUZP1 EFTUD2 KIAA1671 PTPN13 MTUS1 ANLN NAV1 H2AX PEAK1 RAPGEF2 PLEKHA7	8.17e-07	1118	131	23	int:YWHAQ
Interaction	H2AZ1 interactions	MTA2 RC3H2 MAPT ZC3H18 RFC1 JMJD1C PARP1 BRD2 ANLN CFDP1 NUCKS1 H2AX TXNDC2	9.27e-07	371	131	13	int:H2AZ1
Interaction	PSIP1 interactions	NPM1 ZC3H18 REST EFTUD2 PARP1 BRD2 ANLN NUCKS1 H2AX SON	9.43e-07	205	131	10	int:PSIP1
Interaction	AP2B1 interactions	RC3H2 LIMA1 GGA2 FN1 MAPT HIP1R APC TNRC6B WNK1 EFTUD2 KIAA1671 ANLN NAV1	9.85e-07	373	131	13	int:AP2B1
Interaction	LYN interactions	MYBBP1A LIMA1 ANK2 SF3A1 SLITRK4 APC DZIP1 GPRIN1 ADD3 EFTUD2 PTPN13 BRD2 ANLN LTV1 ATP13A3 PEAK1 ADGRL2 PLEKHA7	9.88e-07	720	131	18	int:LYN
Interaction	SLC6A4 interactions	MAGI1 FN1 PPP1R12A APC KIAA1549 STOX1 GABBR2 LUZP1 ADD3 NEFM PTPN13 CASKIN1 DYNC1LI1 RAPGEF2	1.01e-06	437	131	14	int:SLC6A4
Interaction	CAPZB interactions	NPM1 RC3H2 LIMA1 FN1 MAPT PPP1R12A NACA TNRC6B TACC2 UBN2 CLIP1 LUZP1 EFTUD2 KIAA1671 NEFM PARP1 ANLN MDC1 DYNC1LI1 LTV1 PEAK1 DYNC1LI2	1.07e-06	1049	131	22	int:CAPZB
Interaction	ZNF330 interactions	NOLC1 NPM1 MYBBP1A BCORL1 ZC3H18 RFC1 MORC2 DNTTIP2 WDR43 ZNF512B PARP1 BRD2 ANLN CFDP1	1.28e-06	446	131	14	int:ZNF330
Interaction	CALD1 interactions	LIMA1 PPP1R12A UBN2 LUZP1 KIAA1671 NEFM PARP1 DYNC1LI1 LMOD1 PEAK1 DYNC1LI2	1.30e-06	265	131	11	int:CALD1
Interaction	PPP1CC interactions	NPM1 RC3H2 MYBBP1A LIMA1 MYCBP2 MAPT PPP1R12A APC TACC2 ZC3H18 EFTUD2 KIAA1671 MTUS1 ANLN NAV1 ASXL2 PEAK1 SON	1.40e-06	738	131	18	int:PPP1CC
Interaction	YWHAG interactions	NOLC1 MAGI1 RC3H2 LIMA1 FN1 MYCBP2 MAPT PPP1R12A DCP2 APC DZIP1 WNK1 DNTTIP2 LUZP1 EFTUD2 KIAA1671 PTPN13 MTUS1 ANLN NAV1 PEAK1 RAPGEF2 PLEKHA7 SON	1.50e-06	1248	131	24	int:YWHAG
Interaction	EWSR1 interactions	NPM1 RC3H2 IL16 FN1 MYCBP2 MAPT RBM33 NACA BCORL1 HIP1R ZC3H18 REST UBN2 EFTUD2 PARP1 ANLN MDC1 CFDP1 NUCKS1 SMN1	1.61e-06	906	131	20	int:EWSR1
Interaction	CBX2 interactions	NPM1 MYCBP2 BCORL1 PHC2 PCGF6 PARP1 MDC1 H2AX	1.70e-06	126	131	8	int:CBX2
Interaction	ACTB interactions	MTA2 NPM1 LIMA1 FN1 MAP4 MAPT PPP1R12A HIP1R GPRIN1 LUZP1 ADD3 EFTUD2 KIAA1671 FSIP2 PARP1 ANLN LPP H2AX DYNC1LI1 LMOD1 SMN1 PEAK1	1.81e-06	1083	131	22	int:ACTB
Interaction	SMARCA4 interactions	MTA2 NPM1 MYBBP1A SF3A1 PPP1R12A REST EFTUD2 PARP1 BRD2 ANLN MDC1 AHR NUCKS1 H2AX	1.93e-06	462	131	14	int:SMARCA4
Interaction	RPL31 interactions	NOLC1 NPM1 RC3H2 MYBBP1A FN1 MAPT NACA ZC3H18 REST RFC1 DNTTIP2 WDR43 EFTUD2 ZNF512B BRD2 ANLN LTV1	2.03e-06	680	131	17	int:RPL31
Interaction	HNRNPR interactions	MTA2 NPM1 RC3H2 MYBBP1A FN1 MAP4 MAPT SF3A1 ZC3H18 REST EFTUD2 PARP1 ANLN H2AX SMN1	2.17e-06	536	131	15	int:HNRNPR
Interaction	RFC4 interactions	NPM1 FN1 ZC3H18 RFC1 FAN1 EFTUD2 PARP1 BRD2 ANLN MDC1	2.37e-06	227	131	10	int:RFC4
Interaction	GIGYF1 interactions	MAGI1 LIMA1 TSHZ2 TNRC6B PTPN13 ANLN NAV1 ZNF598 PLEKHA7	2.39e-06	177	131	9	int:GIGYF1
Interaction	YWHAH interactions	NOLC1 MAGI1 LIMA1 FN1 MYCBP2 MAPT PPP1R12A APC DZIP1 WNK1 LUZP1 EFTUD2 KIAA1671 PTPN13 MTUS1 ANLN LPP NAV1 PEAK1 HERC1 RAPGEF2 PLEKHA7	2.40e-06	1102	131	22	int:YWHAH
Interaction	WDR18 interactions	NPM1 MYCBP2 ZC3H18 RFC1 ANLN MDC1 H2AX SMN1	2.55e-06	133	131	8	int:WDR18
Interaction	FLOT1 interactions	MAGI1 LIMA1 FN1 ANK2 APC KIAA1549 DZIP1 GPRIN1 ADD3 PTPN13 ANLN PEAK1 ADGRL2 PLEKHA7	2.67e-06	475	131	14	int:FLOT1
Interaction	NAP1L1 interactions	NPM1 RC3H2 MAPT ZC3H18 WDR43 EFTUD2 PARP1 CEP120 ANLN CFDP1 H2AX LTV1	2.68e-06	345	131	12	int:NAP1L1
Interaction	EXOSC2 interactions	NPM1 RC3H2 ZC3H18 WDR43 EFTUD2 ANLN MDC1 EIF4G2 ASXL2	2.75e-06	180	131	9	int:EXOSC2
Interaction	H2AC21 interactions	RC3H2 MYBBP1A MAP4 ZC3H18 PARP1 BRD2 ANLN CFDP1 NUCKS1 H2AX	3.11e-06	234	131	10	int:H2AC21
Interaction	SMARCA5 interactions	MTA2 NPM1 MYBBP1A PPP1R12A ZC3H18 REST EFTUD2 ZNF512B PARP1 BRD2 ANLN NUCKS1 H2AX	3.20e-06	415	131	13	int:SMARCA5
Interaction	ANXA2 interactions	NPM1 LIMA1 FN1 MAPT ZC3H18 EFTUD2 ANLN H2AX DYNC1LI1 SMN1 ASXL2 ZNF598 DYNC1LI2	3.55e-06	419	131	13	int:ANXA2
Interaction	USP7 interactions	PCNP MYBBP1A LIMA1 ZAN MAPT PPP1R12A BCORL1 LCA5L NUP98 APC RFC1 GABBR2 PHC2 EFTUD2 PCGF6 PARP1 ANLN MDC1 SYCP1 H2AX LMOD1 LTV1 HERC1 UTP14C	3.62e-06	1313	131	24	int:USP7
Interaction	HNRNPC interactions	MTA2 NPM1 RC3H2 MYBBP1A FN1 MAP4 MAPT SF3A1 PPP1R12A ZC3H18 F8 DNTTIP2 EFTUD2 ANLN MDC1 H2AX	3.69e-06	634	131	16	int:HNRNPC
Interaction	MYH10 interactions	MTA2 NPM1 FN1 PPP1R12A APC ZC3H18 EFTUD2 ZNF512B NEFM PARP1 ANLN ZNF598	4.03e-06	359	131	12	int:MYH10
Interaction	DYNLT1 interactions	KIAA0586 NUP98 CLIP1 LUZP1 ADD3 KIAA1671 MTUS1 DYNC1LI1 LTV1 DYNC1LI2	4.04e-06	241	131	10	int:DYNLT1
Interaction	RCOR1 interactions	MTA2 NPM1 MYCBP2 PPP1R12A BCORL1 APC TNRC6B REST JMJD1C LUZP1 NEFM PTPN13 NUCKS1 H2AX	4.20e-06	494	131	14	int:RCOR1
Interaction	PKM interactions	NPM1 RC3H2 FN1 MAPT ZC3H18 CLIP1 EFTUD2 ANLN SYCP1 H2AX SMN1 ASXL2 HERC1 ZNF598	4.50e-06	497	131	14	int:PKM
Interaction	TRIM36 interactions	MAP4 MAPT APC CLIP1 LUZP1 ZNF512B MTUS1 NAV1	4.61e-06	144	131	8	int:TRIM36
Interaction	ECT2 interactions	NOLC1 NPM1 LIMA1 MYCBP2 PPP1R12A LCA5L NUP98 CD55 TNRC6B LUZP1 WDR43 EFTUD2 KIAA1671 PARP1 ANLN MDC1 NAV3 SMN1 SON	4.67e-06	887	131	19	int:ECT2
Interaction	PPIA interactions	MTA2 NPM1 FN1 RBM33 PPP1R12A NACA HIP1R TNRC6B ZC3H18 RFC1 CLIP1 EFTUD2 ANLN NUCKS1 H2AX DYNC1LI1 ASXL2 ZNF598 DYNC1LI2	4.75e-06	888	131	19	int:PPIA
Interaction	FLNA interactions	NPM1 RC3H2 LIMA1 FN1 MAP4 MAPT PPP1R12A APC LUZP1 EFTUD2 ANLN MDC1 DYNC1LI1 ASXL2 ZNF598 DYNC1LI2	4.87e-06	648	131	16	int:FLNA
Interaction	CHMP4B interactions	NOLC1 NPM1 MYBBP1A LIMA1 MYCBP2 MAPT PPP1R12A NUP98 CD55 ZC3H18 LUZP1 EFTUD2 KIAA1671 ANLN CAPN7 SMN1 SON	4.96e-06	727	131	17	int:CHMP4B
Interaction	H2BC8 interactions	NPM1 BCORL1 RFC1 MORC2 DNTTIP2 WDR43 PHC2 ZNF512B PARP1 BRD2 ANLN MDC1 CFDP1 NUCKS1 H2AX	5.21e-06	576	131	15	int:H2BC8
Interaction	CLASP2 interactions	RC3H2 MYCBP2 MAPT APC CLIP1 EFTUD2 DYNC1LI1 ZNF598	5.37e-06	147	131	8	int:CLASP2
Interaction	CLTC interactions	NPM1 RC3H2 LIMA1 GGA2 FN1 MAPT HIP1R TNRC6B WNK1 EFTUD2 MTUS1 ANLN ASXL2 HERC1 ZNF598 SON	5.57e-06	655	131	16	int:CLTC
Interaction	BICD1 interactions	NPM1 TNRC6B CLIP1 LUZP1 KIAA1671 PPP2R3A CEP120 ANLN NAV1 DYNC1LI1	5.59e-06	250	131	10	int:BICD1
Interaction	HNRNPAB interactions	RC3H2 FN1 MAP4 MAPT ZC3H18 REST EFTUD2 PARP1 ANLN MDC1 H2AX LTV1	5.64e-06	371	131	12	int:HNRNPAB
Interaction	NOP58 interactions	NOLC1 RC3H2 MYBBP1A FN1 MAP4 ZC3H18 WDR43 EFTUD2 PARP1 ANLN SMN1	5.72e-06	309	131	11	int:NOP58
Interaction	CEP120 interactions	ANK2 KIAA0586 TNRC6B LUZP1 KIAA1671 CEP120 LTV1	5.96e-06	106	131	7	int:CEP120
Interaction	RPS20 interactions	NPM1 RC3H2 FN1 MAP4 MAPT TNRC6B ZC3H18 REST EFTUD2 ANLN EIF4G2 LTV1 ZNF598 DYNC1LI2	6.46e-06	513	131	14	int:RPS20
Interaction	GTPBP4 interactions	NPM1 RC3H2 MYBBP1A GGA2 FN1 ZC3H18 JMJD1C WDR43 EFTUD2 PARP1 BRD2 ANLN EIF4G2	6.49e-06	443	131	13	int:GTPBP4
Interaction	CENPA interactions	MTA2 NPM1 BCORL1 RFC1 MORC2 UBN2 DNTTIP2 PHC2 ZNF512B PARP1 BRD2 H2AX	6.63e-06	377	131	12	int:CENPA
Interaction	RANGAP1 interactions	MYCBP2 MAPT ZC3H18 CLIP1 SLC4A3 EFTUD2 PARP1 LPP H2AX DYNC1LI1 ASXL2	6.65e-06	314	131	11	int:RANGAP1
Interaction	SIRT7 interactions	MTA2 NOLC1 NPM1 MYBBP1A FN1 MYCBP2 MAP4 SF3A1 NUP98 ZC3H18 RFC1 DNTTIP2 WDR43 NEFM MDC1 H2AX SON	6.72e-06	744	131	17	int:SIRT7
Interaction	XRCC5 interactions	NPM1 RC3H2 FN1 ZC3H18 RFC1 MORC2 TRDN EFTUD2 PARP1 ANLN MDC1 NUCKS1 H2AX PEAK1	6.75e-06	515	131	14	int:XRCC5
Interaction	HNRNPA2B1 interactions	NPM1 RC3H2 FN1 MYCBP2 MAPT SF3A1 DCP2 ZC3H18 F8 EFTUD2 NEFM CCNB3 ANLN CFDP1 H2AX SMN1 DYNC1LI2	8.01e-06	754	131	17	int:HNRNPA2B1
Interaction	RFC5 interactions	NPM1 RC3H2 RFC1 EFTUD2 PARP1 BRD2 ANLN MDC1 NUCKS1	8.25e-06	206	131	9	int:RFC5
Interaction	H3C15 interactions	FN1 ANK2 ZC3H18 REST DNTTIP2 FSIP2 PARP1 NUCKS1 H2AX	8.57e-06	207	131	9	int:H3C15
Interaction	PTEN interactions	NPM1 MYBBP1A LIMA1 FN1 NACA NUP98 GPRIN1 LUZP1 ADD3 EFTUD2 FSIP2 MYOF PARP1 PTPN13 MDC1 AHR H2AX LTV1 SON	9.04e-06	929	131	19	int:PTEN
Cytoband	11q12-q13.1	MTA2 MYRF	1.22e-04	6	132	2	11q12-q13.1
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAPT PPP1R12A APC WNK1 PCIF1 HYDIN	6.58e-05	181	69	6	694
GeneFamily	Parkinson disease associated genes\|ATPase orphan transporters	ATP13A5 ATP13A3	1.42e-04	5	69	2	1213
GeneFamily	PDZ domain containing	MAGI1 IL16 PTPN13 RAPGEF2 NOS1	2.87e-04	152	69	5	1220
GeneFamily	Zinc fingers CXXC-type	CXXC4 TET3	9.24e-04	12	69	2	136
GeneFamily	Dyneins, cytoplasmic	DYNC1LI1 DYNC1LI2	1.09e-03	13	69	2	538
GeneFamily	Ankyrin repeat domain containing	ANK2 PPP1R12A BCORL1 CASKIN1 ANKEF1	2.31e-03	242	69	5	403
GeneFamily	Fibronectin type III domain containing	FN1 ABI3BP NEO1 IL6ST	3.27e-03	160	69	4	555
GeneFamily	Ataxins\|Trinucleotide repeat containing	MAGI1 TNRC6B	4.07e-03	25	69	2	775
GeneFamily	Zinc fingers CCCH-type	RC3H2 ZC3H18	7.87e-03	35	69	2	73
Coexpression	AIZARANI_LIVER_C20_LSECS_3	NOLC1 LIMA1 F8 JMJD1C DNTTIP2 LUZP1 WDR43 PHC2 NAV1 PEAK1 HERC1 IL6ST	3.18e-08	295	131	12	M39121
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PCNP NPM1 IL16 GGA2 MYCBP2 RBM33 SF3A1 PPP1R12A DCP2 NUP98 TNRC6B REST WNK1 CLIP1 JMJD1C DNTTIP2 LUZP1 RASGRP1 PARP1 EIF4G2 AHR PCNX1 ASXL2 HERC1 SON	8.64e-08	1492	131	25	M40023
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ANK2 MYCBP2 TSHZ2 RBM33 SLITRK4 APC KIAA1549 CEND1 GABBR2 UBN2 CLIP1 SLC4A3 FSIP2 PPP2R3A MTUS1 CASKIN1 NAV3 NAV1 HERC1 HYDIN GABRA2	1.41e-07	1106	131	21	M39071
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PPP1R12A PHC2 MTUS1 MDC1 LPP NAV3 AHR ATP13A3 RAPGEF2 ADGRL2	2.83e-06	300	131	10	M8702
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	NPM1 LIMA1 MYCBP2 APC CD55 DZIP1 RFC1 CLIP1 ADD3 PPP2R3A PTPN13 MTUS1 ANLN SON	5.46e-06	656	131	14	M18979
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	PCNP RBM33 SF3A1 HIP1R JMJD1C ZNF512B PCNX1 RAPGEF2 IL6ST DYNC1LI2 SON	1.16e-05	432	131	11	M41149
Coexpression	GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS	FN1 ADD3 LPP NUCKS1 IL6ST GABRA2	1.26e-05	102	131	6	M43620
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	NPM1 IL16 MYCBP2 PPP1R12A DCP2 TNRC6B REST WNK1 RASGRP1 BRD2 EIF4G2 NUCKS1 PCNX1 ASXL2 HERC1 SON	1.31e-05	911	131	16	M40038
Coexpression	YOSHIMURA_MAPK8_TARGETS_DN	NOLC1 MAGI1 FN1 MYCBP2 NUP98 NEO1 AHR PLEKHA7 IL6ST DYNC1LI2	2.17e-05	379	131	10	M1885
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	NOLC1 RC3H2 MYBBP1A LIMA1 TNRC6B DZIP1 REST WNK1 LPP NAV1 NUCKS1	2.38e-05	467	131	11	M1347
Coexpression	AIZARANI_LIVER_C29_MVECS_2	NOLC1 LIMA1 ABI3BP CD55 F8 JMJD1C LUZP1 MYOF CLEC3B	2.91e-05	313	131	9	M39128
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	PPP1R12A WNK1 LPP HERC1 RAPGEF2 ADGRL2 IL6ST	3.14e-05	177	131	7	M39245
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	NOLC1 RC3H2 MYBBP1A LIMA1 TNRC6B DZIP1 REST WNK1 LPP NAV1 NUCKS1	3.29e-05	484	131	11	MM999
Coexpression	GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	LIMA1 DZIP1 RASGRP1 PTPN13 HERC1 RAPGEF2 IL6ST	3.50e-05	180	131	7	M6878
Coexpression	ZHONG_PFC_C3_MICROGLIA	ANK2 MAP4 MAPT HIP1R TACC2 GPRIN1 NEFM NEO1 PTPN13 CXXC4 NAV1	3.55e-05	488	131	11	M39104
Coexpression	TRAVAGLINI_LUNG_ARTERY_CELL	LIMA1 FN1 ABI3BP F8 ATP13A3 NOS1	5.21e-05	131	131	6	M41662
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	HEMGN ATP13A5 ANLN LPP NUCKS1 H2AX PCNX1	5.62e-05	194	131	7	M7467
Coexpression	GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	PPP1R12A NACA PHC2 PPP2R3A MTUS1 MDC1 MYRF	6.60e-05	199	131	7	M8415
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	MYCBP2 TNRC6B UBN2 PCIF1 NUCKS1 ATP13A3 RAPGEF2	6.81e-05	200	131	7	M8497
Coexpression	GSE3982_MAC_VS_BCELL_UP	GABBR2 LUZP1 PPP2R3A PTPN13 HP LPP DYNC1LI2	6.81e-05	200	131	7	M5494
Coexpression	GRYDER_PAX3FOXO1_TOP_ENHANCERS	NOLC1 MAGI1 GGA2 DCP2 NACA TFAP2B DNTTIP2 WDR43 PARP1 ANLN	7.74e-05	441	131	10	M172
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	PCNP NPM1 PPP1R12A APC WDR43 PPP2R3A ANLN CFDP1 EIF4G2 DYNC1LI2 UTP14C	7.96e-05	534	131	11	MM1054
Coexpression	MORI_MATURE_B_LYMPHOCYTE_UP	GGA2 MYCBP2 WDR43 LPP BARX1	1.17e-04	95	131	5	M17083
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	APC CD55 DZIP1 RASGRP1 ADGRL2 IL6ST	1.19e-04	152	131	6	M2938
Coexpression	WANG_SMARCE1_TARGETS_UP	LIMA1 FN1 TSHZ2 CD55 GABBR2 PTPN13 LPP GABRA2	1.20e-04	294	131	8	M1804
Coexpression	TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL	LIMA1 ANK2 ABI3BP TSHZ2 CD55 ADD3 AHR CLEC3B	1.25e-04	296	131	8	M41675
Coexpression	HAY_BONE_MARROW_STROMAL	MAGI1 LIMA1 FN1 ANK2 ABI3BP NCKAP5 TACC2 DZIP1 PTPN13 HP NAV3 ADGRL2 IL6ST	1.27e-04	767	131	13	M39209
Coexpression	FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL	NOLC1 NPM1 NACA CD55 JMJD1C LUZP1 WDR43 EIF4G2 H2AX	1.29e-04	380	131	9	M41703
Coexpression	WANG_TUMOR_INVASIVENESS_UP	NPM1 FN1 NACA CEND1 RFC1 NEFM BRD2 EIF4G2 NUCKS1	1.39e-04	384	131	9	M1865
Coexpression	AIZARANI_LIVER_C9_LSECS_1	LIMA1 F8 JMJD1C LUZP1 PHC2 HERC1 ADGRL2 IL6ST	1.50e-04	304	131	8	M39113
Coexpression	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	MAPT PPP2R3A BRD2 MDC1 MYRF DYNC1LI2	1.57e-04	160	131	6	M11011
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	NOLC1 NPM1 MAGI1 GGA2 ANK2 DCP2 NACA WNK1 TFAP2B DNTTIP2 WDR43 PARP1 ANLN NAV1 NOS1	1.61e-04	1009	131	15	M157
Coexpression	BROWNE_HCMV_INFECTION_20HR_DN	ADD3 PTPN13 LPP AHR ATP13A3	1.63e-04	102	131	5	M5601
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_DN	NOLC1 FN1 PPP1R12A APC TACC2 DZIP1 GABBR2 CLIP1 SLC4A3 F8 NEFM PARP1 DYNC1LI1 HERC1 ADGRL2 GABRA2 SON	1.65e-04	1248	131	17	M17728
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	BCORL1 CD55 DZIP1 RASGRP1 ADGRL2 TET3	1.68e-04	162	131	6	M7002
Coexpression	MORI_MATURE_B_LYMPHOCYTE_UP	GGA2 MYCBP2 WDR43 LPP BARX1	1.95e-04	106	131	5	MM595
Coexpression	WANG_TUMOR_INVASIVENESS_UP	NPM1 FN1 NACA CEND1 RFC1 NEFM BRD2 EIF4G2 NUCKS1	1.96e-04	402	131	9	MM1248
Coexpression	HALLMARK_MYC_TARGETS_V2	NOLC1 NPM1 MYBBP1A WDR43	2.05e-04	58	131	4	M5928
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	LIMA1 JMJD1C MTUS1 HERC1 RAPGEF2 ADGRL2 IL6ST	2.11e-04	240	131	7	M39236
Coexpression	ONDER_CDH1_TARGETS_1_DN	MAP4 NUP98 NAV3 ATP13A3 IL6ST UTP14C	2.18e-04	170	131	6	M6822
Coexpression	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	CD55 DZIP1 PCGF6 MDC1 IL6ST SON	2.55e-04	175	131	6	M2940
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	MAPT KIAA1549 TNRC6B NCKAP5 DZIP1 GABBR2 KIAA1671 CFDP1 PLEKHA7	2.57e-04	417	131	9	M39224
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	PCNP NPM1 PPP1R12A APC WDR43 PPP2R3A ANLN CFDP1 EIF4G2 DYNC1LI2	3.07e-04	523	131	10	M12707
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_B	PCNP NPM1 CD55 WNK1 TFAP2B LUZP1 CEP120 MTUS1 ANLN UTP14C	3.21e-04	526	131	10	M2520
Coexpression	GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN	GGA2 CD55 RFC1 ADD3 PARP1 GABRA2	3.24e-04	183	131	6	M8189
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	RC3H2 ABI3BP MAP4 SLITRK4 CD55 REST RFC1 WNK1 ADD3 PCGF6 RASGRP1 BRD2 CCNB3 LPP SYCP1 ASXL2 PEAK1 HERC1 NOS1	2.15e-07	778	128	19	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	MYCBP2 PPP1R12A KIAA0586 APC REST WNK1 CLIP1 JMJD1C ADD3 CEP120 MDC1 CFDP1 ASXL2 RAPGEF2	8.02e-06	564	128	14	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	MAGI1 TSHZ2 DCP2 CD55 DZIP1 RFC1 SLC4A3 NEFM MYOF NEO1 PTPN13 ATP13A3 PEAK1 ADGRL2 MYRF IL6ST	1.99e-05	783	128	16	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500	ABI3BP MAP4 PPP1R12A APC CD55 NEFM MYOF LPP LMOD1 ATP13A3 IL6ST	2.37e-05	388	128	11	gudmap_developingLowerUrinaryTract_P1_bladder_500_J
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	ANK2 MYCBP2 MAP4 MAPT PPP1R12A SLITRK4 APC CD55 TNRC6B WNK1 CLIP1 NEFM ASXL2 ATP13A3 IL6ST SON	3.38e-05	818	128	16	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500	PPP1R12A APC CD55 LPP LMOD1 ATP13A3	4.21e-05	105	128	6	gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_500	PPP1R12A CD55 ATP13A3 IL6ST	7.13e-05	37	128	4	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_500
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500	MYCBP2 APC TFAP2B ASXL2 ATP13A3 PLEKHA7	7.72e-05	117	128	6	gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	MAP4 CD55 RASGRP1 CCNB3 SYCP1 ASXL2 PEAK1 HERC1	7.86e-05	230	128	8	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	RC3H2 GGA2 MAP4 TSHZ2 BCORL1 SLITRK4 REST RFC1 JMJD1C ADD3 BRD2 LPP CXXC4 NAV1 HERC1	8.43e-05	790	128	15	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	RC3H2 MAP4 KIAA0586 BCORL1 SLITRK4 HEMGN ADD3 RASGRP1 BRD2 CCNB3 LPP SYCP1 PEAK1 HERC1 MAJIN	9.04e-05	795	128	15	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000	PPP1R12A CD55 ADD3 LPP IL6ST SON	1.50e-04	132	128	6	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	MAGI1 TSHZ2 CD55 DZIP1 WNK1 SLC4A3 RASGRP1 MYOF NEO1 PTPN13 ATP13A3 PEAK1 ADGRL2 MYRF	1.53e-04	740	128	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000	TSHZ2 BCORL1 SLITRK4 ADD3 LPP CXXC4 NAV1	1.95e-04	197	128	7	gudmap_developingGonad_e16.5_epididymis_1000_k5
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000	MAGI1 SLC4A3 RASGRP1 NEO1 ATP13A3 PEAK1 ADGRL2 IL6ST	2.25e-04	268	128	8	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	PPP1R12A KIAA0586 APC NCKAP5 WNK1 CLIP1 BCO1 MDC1 ASXL2 RAPGEF2 DYNC1LI2 SON	2.59e-04	595	128	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	MAP4 MAPT PPP1R12A APC CD55 NEFM CXXC4 ASXL2 ATP13A3 IL6ST	2.68e-04	427	128	10	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000	ABI3BP PPP1R12A CD55 LPP LMOD1 IL6ST	2.79e-04	148	128	6	gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500	RC3H2 MYBBP1A MAPT HEMGN TFAP2B NEFM PCGF6 BRD2 SMN1 SON	3.22e-04	437	128	10	gudmap_developingGonad_e11.5_testes_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	RC3H2 GGA2 MAP4 TSHZ2 BCORL1 SLITRK4 REST JMJD1C LUZP1 ADD3 BRD2 LPP NAV1 HERC1	3.43e-04	801	128	14	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500	APC CLIP1 TFAP2B ASXL2 ATP13A3 PLEKHA7	3.71e-04	156	128	6	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	NPM1 PPP1R12A KIAA0586 SLITRK4 APC REST WNK1 CLIP1 LUZP1 ASXL2 RAPGEF2 SON	4.28e-04	629	128	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 ABI3BP PPP1R12A TACC2 DZIP1 MYOF MTUS1 LPP LMOD1	8.38e-09	200	131	9	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ2 CD55 F8 ADD3 MTUS1 NAV1 ADGRL2 IL6ST	6.67e-08	181	131	8	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TNRC6B JMJD1C LPP PCNX1 ATP13A3 HERC1 RAPGEF2 IL6ST	8.93e-08	188	131	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYCBP2 MAP4 ADD3 LPP EIF4G2 AHR NAV1 SON	9.69e-08	190	131	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN SLC4A3 PPP2R3A ADGRL2	9.69e-08	190	131	8	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 ABI3BP CD55 NCKAP5 ADD3 PTPN13 CLEC3B MYRF	1.01e-07	191	131	8	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN SLC4A3 PPP2R3A ADGRL2	1.01e-07	191	131	8	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FN1 ABI3BP HIP1R DZIP1 F8 MTUS1 ATP13A3 NOS1	1.14e-07	194	131	8	582db7f7fa9aa08027ae18ed607945b5d1dc908a
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FN1 ABI3BP HIP1R DZIP1 F8 MTUS1 ATP13A3 NOS1	1.14e-07	194	131	8	bda89111386398a072b70e8153b2a762298a047a
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 ABI3BP PPP1R12A DZIP1 MYOF MTUS1 LPP LMOD1	1.38e-07	199	131	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	LIMA1 TNRC6B REST RFC1 CLIP1 MTUS1 LPP NUCKS1	1.38e-07	199	131	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP TSHZ2 TACC2 DZIP1 MYOF MTUS1 LPP LMOD1	1.44e-07	200	131	8	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP TSHZ2 PPP1R12A TACC2 DZIP1 MTUS1 LPP LMOD1	1.44e-07	200	131	8	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 ABI3BP PPP1R12A DZIP1 MYOF MTUS1 LPP LMOD1	1.44e-07	200	131	8	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MAGI1 ABI3BP CD55 NCKAP5 TACC2 PEAK1 MYRF	8.22e-07	173	131	7	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAGI1 FN1 ANK2 TSHZ2 F8 ADD3 MTUS1	1.03e-06	179	131	7	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ABI3BP TSHZ2 SLC1A7 MTUS1 LPP LMOD1 HYDIN	1.34e-06	186	131	7	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	PPP1R12A APC LUZP1 ADD3 LPP ASXL2 TET3	1.34e-06	186	131	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	IL16 FN1 ABI3BP TSHZ2 NAV3 LMOD1 ADGRL2	1.38e-06	187	131	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN SLC4A3 ADGRL2	1.43e-06	188	131	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN PPP2R3A ADGRL2	1.65e-06	192	131	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 TNRC6B NCKAP5 JMJD1C LPP RAPGEF2 PLEKHA7	1.65e-06	192	131	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUP98 JMJD1C LPP PCNX1 ATP13A3 PLEKHA7 IL6ST	1.71e-06	193	131	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN PPP2R3A ADGRL2	1.77e-06	194	131	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	tumor_Lung-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	LIMA1 ABI3BP F8 MYOF AHR CLEC3B NOS1	1.83e-06	195	131	7	56f88ce95495260360bf08f9c76cc36e395dc6a9
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MAGI1 TSHZ2 CD55 F8 KIAA1671 PEAK1 IL6ST	1.83e-06	195	131	7	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ANK2 ABI3BP TACC2 PPP2R3A PTPN13 PLEKHA7	1.89e-06	196	131	7	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 ABI3BP CD55 ADD3 MYOF NEO1 PTPN13	1.89e-06	196	131	7	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-F\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ABI3BP TSHZ2 CD55 ADD3 MTUS1 NAV1 CLEC3B	1.96e-06	197	131	7	fbff2fb7a8142b88c9dc71aa10980f4350b7e081
ToppCell	Control-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	ANK2 ABI3BP TSHZ2 CD55 ADD3 AHR NAV1	1.96e-06	197	131	7	64cc5f61c88e9560b0f8f6f3151255dffb5c3d66
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	NPM1 MYCBP2 NACA TNRC6B ADD3 NUCKS1 SON	2.02e-06	198	131	7	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	IL16 FN1 ANK2 ABI3BP TSHZ2 NAV3 LMOD1	2.02e-06	198	131	7	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TSHZ2 CD55 TACC2 MYOF PPP2R3A NAV3 PLEKHA7	2.02e-06	198	131	7	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	ANK2 MAP4 MAPT GABBR2 NEFM NEO1 ANLN	2.02e-06	198	131	7	60d8d3bbd754ffde41c50013d822667b185a9751
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 FN1 TSHZ2 KIAA1671 MTUS1 CLEC3B ADGRL2	2.09e-06	199	131	7	1c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LIMA1 MYCBP2 TSHZ2 MYOF PTPN13 LPP IL6ST	2.09e-06	199	131	7	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LIMA1 MYCBP2 TSHZ2 MYOF PTPN13 LPP IL6ST	2.09e-06	199	131	7	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LIMA1 MYCBP2 TSHZ2 MYOF PTPN13 LPP IL6ST	2.09e-06	199	131	7	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP TACC2 DZIP1 MYOF MTUS1 LPP LMOD1	2.16e-06	200	131	7	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LIMA1 TSHZ2 TACC2 CLIP1 CFDP1 EIF4G2 DYNC1LI2	2.16e-06	200	131	7	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	facs-Brain_Non-Myeloid-Hippocampus\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIP1R APC WNK1 ADD3 PHC2 EIF4G2 MYRF	2.16e-06	200	131	7	fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 ANK2 ABI3BP TSHZ2 NAV3 LMOD1	2.16e-06	200	131	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	NCKAP5 LUZP1 ADD3 EIF4G2 AHR ADGRL2 DYNC1LI2	2.16e-06	200	131	7	041a34080120c9f613373c20dcc366292f558040
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPM1 ABI3BP TACC2 MYOF MTUS1 LPP LMOD1	2.16e-06	200	131	7	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP PPP1R12A TACC2 DZIP1 MTUS1 LPP LMOD1	2.16e-06	200	131	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 ANK2 ABI3BP TSHZ2 SLC1A7 NAV3 NAV1	2.16e-06	200	131	7	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP PPP1R12A TACC2 DZIP1 MYOF LPP LMOD1	2.16e-06	200	131	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA1549 GABBR2 F8 CAPN7 PCNX1 HERC1	1.29e-05	174	131	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	AT1-AT2_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 FAM178B BARX2 GABBR2 NYAP1 MYRF	1.56e-05	180	131	6	3c7b2033821f9e34e2924bd8655f566edcbcc7d3
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 MAP4 TSHZ2 MAPT F8 ADD3	1.56e-05	180	131	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3BP CD55 TACC2 F8 MYOF ATP13A3	1.56e-05	180	131	6	67c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 MAP4 TSHZ2 MAPT F8 ADD3	1.56e-05	180	131	6	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	TSHZ2 TNRC6B JMJD1C LPP HERC1 IL6ST	1.61e-05	181	131	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPM1 ABI3BP HEMGN STOX1 ADD3 IL6ST	1.61e-05	181	131	6	55fcefa234c8fc707b23248e724756d69827cd18
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAGI1 ABI3BP F8 NAV3 NYAP1 IL6ST	1.71e-05	183	131	6	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 TACC2 PTPN13 MTUS1 AHR MUCL3	1.71e-05	183	131	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAGI1 FN1 TSHZ2 F8 KIAA1671 MTUS1	1.82e-05	185	131	6	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MAGI1 HIP1R KIAA1549 MORC2 MTUS1 PLEKHA7	1.82e-05	185	131	6	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ2 F8 BCO1 PTPN13 NAV1 IL6ST	1.82e-05	185	131	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 TACC2 PTPN13 MTUS1 AHR MUCL3	1.88e-05	186	131	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BARX2 WNK1 RASGRP1 PPP2R3A PTPN13 GABRA2	1.88e-05	186	131	6	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TACC2 MYOF PTPN13 MTUS1 PLEKHA7 MYRF	1.88e-05	186	131	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	MAGI1 NCKAP5 TACC2 PTPN13 MTUS1 AHR	1.88e-05	186	131	6	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	MAGI1 NCKAP5 TACC2 PTPN13 MTUS1 AHR	1.88e-05	186	131	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 TACC2 PTPN13 MTUS1 AHR MUCL3	1.88e-05	186	131	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 ABI3BP CD55 NCKAP5 CLEC3B MYRF	1.93e-05	187	131	6	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic-Progen\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPM1 ABI3BP HEMGN STOX1 ADD3 IL6ST	1.93e-05	187	131	6	16fffe894a2c7d5186556ad000e0be229511fbdb
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 CD55 TACC2 PTPN13 MTUS1 PLEKHA7	1.99e-05	188	131	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	IL16 ANK2 ABI3BP TSHZ2 SLC1A7 NAV3	1.99e-05	188	131	6	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	MAGI1 TACC2 PTPN13 MTUS1 AHR MUCL3	1.99e-05	188	131	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MAGI1 CD55 TACC2 PTPN13 MTUS1 PLEKHA7	1.99e-05	188	131	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	ANK2 NCKAP5 TACC2 TRDN PPP2R3A ADGRL2	2.05e-05	189	131	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 ANK2 TACC2 TRDN PPP2R3A ADGRL2	2.05e-05	189	131	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FN1 KIAA1671 NAV1 CLEC3B ATP13A3 NOS1	2.05e-05	189	131	6	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ABI3BP TSHZ2 MYOF PTPN13 DYNC1LI1	2.05e-05	189	131	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ANK2 ABI3BP TSHZ2 DZIP1 NAV3 NAV1	2.11e-05	190	131	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FN1 ANK2 ABI3BP TSHZ2 F8 ADD3	2.11e-05	190	131	6	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 ANK2 TACC2 TRDN PPP2R3A ADGRL2	2.18e-05	191	131	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	MAGI1 NCKAP5 TACC2 PTPN13 MTUS1 AHR	2.18e-05	191	131	6	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FN1 ABI3BP TSHZ2 NCKAP5 ADGRL2 GABRA2	2.18e-05	191	131	6	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 MAPT CEND1 NEFM MTUS1 BARX1	2.24e-05	192	131	6	307d64ef7add6a2778733e9945a1bd687feb6f44
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 ABI3BP MYCBP2 JMJD1C ADD3 CLEC3B	2.24e-05	192	131	6	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 TSHZ2 MAPT F8 NYAP1 IL6ST	2.24e-05	192	131	6	6806a1a9fe00395dc1abc3e0124b4261dc701f31
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 ABI3BP PPP1R12A MYOF LPP LMOD1	2.24e-05	192	131	6	d0fb6885f023d55a2b7984c99db9c6463258f788
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FN1 ANK2 ABI3BP TSHZ2 F8 ADD3	2.24e-05	192	131	6	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 ABI3BP CD55 ADD3 MYOF PTPN13	2.24e-05	192	131	6	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ANK2 NCKAP5 TACC2 TRDN PPP2R3A ATP13A3	2.31e-05	193	131	6	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL16 ABI3BP TSHZ2 TRDN NAV3 LMOD1	2.31e-05	193	131	6	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD55 F8 LUZP1 BCO1 PEAK1 IL6ST	2.31e-05	193	131	6	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	LA\|World / Chamber and Cluster_Paper	IL16 FN1 ABI3BP TSHZ2 HP LMOD1	2.31e-05	193	131	6	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1R BARX2 WNK1 RASGRP1 PTPN13 GABRA2	2.31e-05	193	131	6	d994b2f2707877288f88cab7cd6002ef91962c50
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 NCKAP5 PTPN13 MTUS1 AHR IL6ST	2.38e-05	194	131	6	5b29c843186c2394f5bec3b1d5ae284a0d931d85
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADD3 PPP2R3A PTPN13 MTUS1 ANLN MYRF	2.38e-05	194	131	6	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL16 ABI3BP TSHZ2 NAV3 NAV1 LMOD1	2.38e-05	194	131	6	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 NCKAP5 PTPN13 MTUS1 AHR IL6ST	2.38e-05	194	131	6	ebcf6c6d0eb20a5d422becf5a730089230c8ba9a
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MAGI1 ANK2 NCKAP5 TACC2 TRDN ADGRL2	2.38e-05	194	131	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 NCKAP5 PTPN13 MTUS1 AHR IL6ST	2.38e-05	194	131	6	8c6e5ba27a988e0cd6b8c25cb9a30a0da2b1f7f9
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 NCKAP5 PTPN13 MTUS1 AHR IL6ST	2.38e-05	194	131	6	6e78e3046c5b172af92a84e25f982377a0aaac58
ToppCell	18-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	ANK2 MAPT CEND1 GPRIN1 NOS1 GABRA2	2.38e-05	194	131	6	d3c90e1f1228f8ba0ba56105c6cf4f302c388f28
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	NPM1 TSHZ2 TNRC6B ADD3 RASGRP1 IL6ST	2.45e-05	195	131	6	4bdedd924564a260841a9153604026b57487c83d
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	RC3H2 MYCBP2 MAP4 PPP1R12A WNK1 ADD3 PPP2R3A RAPGEF2 IL6ST SON	8.44e-08	178	131	10	3998_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	RC3H2 GGA2 ABI3BP MAP4 REST WNK1 MTUS1 PCNX1 RAPGEF2 IL6ST	1.89e-07	194	131	10	4312_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	MTA2 KIAA0586 NUP98 APC CLIP1 SLC1A7 LUZP1 PPP2R3A H2AX PCNX1	1.98e-07	195	131	10	5004_DN
Drug	bromfenacoum	PCNP NOLC1 MYBBP1A MAP4 SF3A1 PPP1R12A NACA NUP98 APC TNRC6B ZC3H18 LUZP1 CASKIN1 CFDP1 NUCKS1 NOS1	9.48e-07	644	131	16	ctd:C013418
Drug	geldanamycin	LIMA1 FN1 ATP13A5 UBN2 CLIP1 JMJD1C PARP1 LPP AHR ATP13A3 RAPGEF2 IL6ST	1.63e-06	371	131	12	ctd:C001277
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	NOLC1 MAP4 APC REST WNK1 LPP PCNX1 RAPGEF2 IL6ST	1.67e-06	191	131	9	4283_DN
Drug	5155877; Down 200; 10uM; MCF7; HT_HG-U133A	GGA2 KIAA0586 ZNF512B MYOF PPP2R3A MTUS1 AHR ATP13A3 PEAK1	2.16e-06	197	131	9	6549_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A	GGA2 FN1 MYCBP2 MAP4 KIAA0586 BCORL1 APC REST ZNF512B	2.16e-06	197	131	9	5311_DN
Drug	aminoflavone	PARP1 AHR H2AX	3.68e-06	6	131	3	ctd:C413760
Drug	Glu-P-2	PARP1 AHR H2AX	3.68e-06	6	131	3	ctd:C023847
Drug	Thimerosal	MTA2 PCNP LIMA1 FN1 ANK2 MAP4 APC RFC1 UBN2 WNK1 JMJD1C LUZP1 FSIP2 ANKEF1 VSIG10L NAV3 PCNX1 ATP13A3 RAPGEF2 TET3 SON	4.87e-06	1199	131	21	ctd:D013849
Drug	2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole	PARP1 AHR H2AX	6.41e-06	7	131	3	ctd:C023785
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	MAP4 MAPT KIAA0586 BCORL1 CD55 SLC1A7 PCNX1 GABRA2	7.08e-06	172	131	8	6989_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	NOLC1 RC3H2 MAP4 PPP1R12A PPP2R3A RAPGEF2 IL6ST SON	1.36e-05	188	131	8	6735_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	ABI3BP MAP4 PPP1R12A REST WNK1 LPP PCNX1 IL6ST	1.46e-05	190	131	8	4306_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	MAP4 PPP1R12A REST WNK1 LPP PCNX1 RAPGEF2 IL6ST	1.52e-05	191	131	8	4303_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	GGA2 APC GABBR2 SLC4A3 MYOF NAV3 MYRF IL6ST	1.64e-05	193	131	8	6646_DN
Drug	yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA	MAP4 MAPT KIAA0586 JMJD1C LUZP1 FAN1 LPP AHR	1.70e-05	194	131	8	1119_UP
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	MTA2 MAP4 APC REST SLC1A7 MYOF EIF4G2 IL6ST	1.77e-05	195	131	8	3309_UP
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A	GABBR2 WNK1 SLC1A7 LUZP1 BCO1 PPP2R3A NEO1 H2AX	1.83e-05	196	131	8	3435_UP
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	MYBBP1A FN1 SLC1A7 MYOF MTUS1 EIF4G2 PCIF1 RAPGEF2	1.83e-05	196	131	8	2978_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIP1R APC SLC1A7 LUZP1 BCO1 MYOF PPP2R3A PCNX1	1.97e-05	198	131	8	3882_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A	MAPT KIAA0586 APC MORC2 PTPN13 PCIF1 H2AX IL6ST	1.97e-05	198	131	8	5515_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A	ABI3BP TNRC6B GABBR2 PPP2R3A EIF4G2 PCNX1 RAPGEF2 IL6ST	1.97e-05	198	131	8	4757_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HG-U133A	RC3H2 GGA2 MAP4 NUP98 RFC1 LPP CFDP1 ATP13A3	2.04e-05	199	131	8	1907_DN
Drug	2-amino-9H-pyrido(2,3-b)indole	PARP1 AHR H2AX	2.17e-05	10	131	3	ctd:C017822
Drug	2-amino-3-methyl-9H-pyrido(2,3-b)indole	PARP1 AHR H2AX	2.97e-05	11	131	3	ctd:C017821
Drug	Nocodazole	NPM1 MAPT PARP1 AHR H2AX	3.14e-05	63	131	5	ctd:D015739
Drug	3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole	PARP1 AHR H2AX	3.94e-05	12	131	3	ctd:C019132
Drug	2-amino-3-methylimidazo(4,5-f)quinoline	APC PARP1 AHR H2AX	4.25e-05	34	131	4	ctd:C029216
Drug	manganese chloride	FN1 TSHZ2 MAPT APC STOX1 GABBR2 TFAP2B PARP1 SYCP1 NUCKS1 NOS1	6.77e-05	456	131	11	ctd:C025340
Drug	satratoxin H	PARP1 H2AX	9.82e-05	3	131	2	ctd:C014184
Drug	4-styrylaniline	AHR LMOD1	9.82e-05	3	131	2	CID000013265
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A	NOLC1 FN1 MYCBP2 MAP4 WDR43 ZNF512B NAV3	1.03e-04	186	131	7	1548_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA	MAPT KIAA0586 BCORL1 ADD3 PPP2R3A ANKEF1 PCNX1	1.07e-04	187	131	7	1047_UP
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MAP4 MAPT KIAA0586 NUP98 CLIP1 PPP2R3A ATP13A3	1.07e-04	187	131	7	4989_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NOLC1 MAP4 WNK1 ZNF512B H2AX IL6ST SON	1.07e-04	187	131	7	4302_DN
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	GGA2 TNRC6B MORC2 CLIP1 RASGRP1 MYOF ATP13A3	1.10e-04	188	131	7	7091_DN
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	MAP4 APC REST WNK1 MTUS1 PCNX1 IL6ST	1.18e-04	190	131	7	4507_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	MTA2 NOLC1 MAP4 WNK1 SLC1A7 PCNX1 IL6ST	1.18e-04	190	131	7	4322_DN
Drug	3-amino-1-methyl-5H-pyrido(4,3-b)indole	PARP1 AHR H2AX	1.19e-04	17	131	3	ctd:C019133
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ABI3BP MAP4 APC WNK1 ZNF512B RAPGEF2 IL6ST	1.22e-04	191	131	7	6020_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	MTA2 MAGI1 FN1 MAPT CLIP1 PPP2R3A EIF4G2	1.22e-04	191	131	7	1665_UP
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	GGA2 MAP4 REST WNK1 MTUS1 PCNX1 IL6ST	1.22e-04	191	131	7	4273_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	MAP4 APC REST LUZP1 MTUS1 PCNX1 IL6ST	1.26e-04	192	131	7	4110_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MAPT APC MTUS1 EIF4G2 PCNX1 RAPGEF2 IL6ST	1.26e-04	192	131	7	6808_DN
Drug	Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A	MTA2 MAP4 KIAA0586 MORC2 RASGRP1 RAPGEF2 IL6ST	1.30e-04	193	131	7	2825_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	NOLC1 MAP4 REST WNK1 LPP IL6ST GABRA2	1.30e-04	193	131	7	4321_DN
Drug	Kaempferol [520-18-3]; Down 200; 14uM; HL60; HT_HG-U133A	MAP4 ZNF512B MYOF MTUS1 LPP RAPGEF2 IL6ST	1.34e-04	194	131	7	6157_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	MTA2 NOLC1 MAP4 DZIP1 WNK1 IL6ST GABRA2	1.34e-04	194	131	7	4320_DN
Drug	Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A	GGA2 MAP4 TNRC6B DZIP1 WNK1 ZNF512B PCNX1	1.34e-04	194	131	7	2433_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	GGA2 FN1 REST GABBR2 WNK1 LPP PCNX1	1.34e-04	194	131	7	4141_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	RC3H2 PPP1R12A RFC1 MYOF DYNC1LI1 PCNX1 IL6ST	1.34e-04	194	131	7	7283_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 PPP2R3A MTUS1 LPP NOS1 IL6ST SON	1.34e-04	194	131	7	4361_DN
Drug	AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A	MAP4 KIAA0586 TFAP2B LUZP1 MYOF PPP2R3A CXXC4	1.38e-04	195	131	7	6903_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 MAPT ZNF512B PTPN13 H2AX PCNX1 IL6ST	1.38e-04	195	131	7	7239_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	MTA2 MAPT REST WNK1 MTUS1 PCNX1 IL6ST	1.38e-04	195	131	7	5109_DN
Drug	Chloramphenicol [56-75-7]; Up 200; 12.4uM; HL60; HT_HG-U133A	MTA2 MAP4 BCORL1 HIP1R REST SLC1A7 IL6ST	1.38e-04	195	131	7	1837_UP
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A	FN1 MYCBP2 MAP4 BCORL1 MYOF CFDP1 SON	1.38e-04	195	131	7	2017_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	MTA2 GGA2 APC REST GABBR2 MTUS1 IL6ST	1.38e-04	195	131	7	4508_DN
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A	GGA2 APC WNK1 PPP2R3A PCNX1 ATP13A3 IL6ST	1.38e-04	195	131	7	6799_DN
Drug	Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	MAGI1 MAP4 MAPT APC LUZP1 H2AX RAPGEF2	1.38e-04	195	131	7	2748_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A	IL16 GGA2 CLIP1 LUZP1 PCNX1 RAPGEF2 SON	1.38e-04	195	131	7	1420_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; HL60; HG-U133A	MYBBP1A FN1 KIAA0586 NUP98 MORC2 ZNF512B CAPN7	1.43e-04	196	131	7	1781_DN
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; HL60; HT_HG-U133A	RC3H2 MYBBP1A FN1 APC DZIP1 ATP13A3 RAPGEF2	1.43e-04	196	131	7	1841_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	NOLC1 MAPT KIAA0586 TNRC6B WNK1 SLC1A7 MYOF	1.43e-04	196	131	7	5016_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A	GGA2 MAP4 SF3A1 APC REST H2AX NOS1	1.43e-04	196	131	7	1867_UP
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A	MAP4 SF3A1 NUP98 CLIP1 F8 MYOF H2AX	1.43e-04	196	131	7	6570_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	MAP4 REST LUZP1 CXXC4 PCIF1 H2AX GABRA2	1.43e-04	196	131	7	6015_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A	MAPT GABBR2 WNK1 NEFM RAPGEF2 IL6ST GABRA2	1.43e-04	196	131	7	4714_UP
Drug	Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MTA2 ABI3BP WNK1 SLC1A7 PCNX1 RAPGEF2 GABRA2	1.47e-04	197	131	7	5616_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	MTA2 TFAP2B SLC1A7 LUZP1 BCO1 MYOF PPP2R3A	1.47e-04	197	131	7	6947_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NACA NUP98 TNRC6B REST WNK1 H2AX PCNX1	1.47e-04	197	131	7	2643_DN
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MTA2 IL16 FN1 APC BCO1 PPP2R3A CXXC4	1.47e-04	197	131	7	1485_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	NOLC1 MAP4 GABBR2 WNK1 SLC4A3 NEO1 MYRF	1.47e-04	197	131	7	3748_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MAPT NACA WNK1 SLC1A7 LUZP1 H2AX PCNX1	1.47e-04	197	131	7	6815_DN
Drug	SC-58125; Up 200; 10uM; HL60; HG-U133A	GGA2 DZIP1 MORC2 MYOF NEO1 LPP NOS1	1.47e-04	197	131	7	542_UP
Drug	Iopromide [73334-07-3]; Down 200; 5uM; PC3; HT_HG-U133A	MAGI1 FN1 REST GABBR2 SLC1A7 IL6ST GABRA2	1.47e-04	197	131	7	4504_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	MTA2 GGA2 MAP4 APC WNK1 PPP2R3A EIF4G2	1.47e-04	197	131	7	1682_UP
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	ANK2 MAP4 REST MTUS1 PCIF1 MYRF IL6ST	1.52e-04	198	131	7	2200_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A	GGA2 FN1 MAP4 BCORL1 REST MORC2 NOS1	1.52e-04	198	131	7	1859_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A	LIMA1 GGA2 FN1 MAP4 KIAA0586 NUP98 MORC2	1.52e-04	198	131	7	2002_DN
Drug	Tridihexethyl chloride; Down 200; 11.4uM; HL60; HT_HG-U133A	FN1 MAP4 APC F8 MTUS1 PCIF1 H2AX	1.52e-04	198	131	7	2964_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MAGI1 MAP4 BCORL1 APC GABBR2 LUZP1 RAPGEF2	1.52e-04	198	131	7	6489_DN
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A	TNRC6B GABBR2 WNK1 MYOF LPP CXXC4 GABRA2	1.52e-04	198	131	7	2369_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MAP4 TNRC6B JMJD1C ZNF512B PPP2R3A ANKEF1 LPP	1.57e-04	199	131	7	7009_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MAGI1 RC3H2 MAPT APC PPP2R3A PCNX1 IL6ST	1.57e-04	199	131	7	4390_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; HL60; HT_HG-U133A	IL16 FN1 ANK2 DZIP1 MYOF PCNX1 ATP13A3	1.57e-04	199	131	7	1295_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MTA2 GGA2 MAP4 REST LUZP1 PPP2R3A GABRA2	1.57e-04	199	131	7	3205_DN
Drug	carmustine; Down 200; 100uM; MCF7; HT_HG-U133A	MAGI1 APC ADD3 MYOF CXXC4 PCNX1 RAPGEF2	1.57e-04	199	131	7	6888_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A	GGA2 MYCBP2 MAP4 GABBR2 WNK1 MTUS1 ATP13A3	1.57e-04	199	131	7	122_DN
Drug	tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A	WNK1 LUZP1 ADD3 AHR DYNC1LI1 PCNX1 NOS1	1.57e-04	199	131	7	143_UP
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	MAPT DZIP1 WNK1 SLC4A3 SLC1A7 NEO1 MTUS1	1.57e-04	199	131	7	3759_DN
Drug	(+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA	MTA2 MYCBP2 BCORL1 TNRC6B REST PHC2 MTUS1	1.57e-04	199	131	7	954_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	MTA2 GGA2 MAPT APC GABBR2 SLC1A7 H2AX	1.57e-04	199	131	7	4228_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	NUP98 REST MORC2 PTPN13 LPP H2AX PCNX1	1.57e-04	199	131	7	7255_DN
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A	FN1 MAP4 KIAA0586 NUP98 CAPN7 CFDP1 NOS1	1.57e-04	199	131	7	2045_DN
Drug	DB01888	SSX9P SSX7 BRD2	1.69e-04	19	131	3	CID005287990
Drug	AC1N9ZZC	ANK2 CD55 NEO1 NAV3 NAV1 SMN1	2.27e-04	149	131	6	CID004369374
Drug	MDL 28170	ANK2 NEFM CAPN7 AHR	2.65e-04	54	131	4	CID000072430
Disease	cortical surface area measurement	MAGI1 ZAN MYCBP2 MAPT FAM178B APC TNRC6B NCKAP5 REST STOX1 TFAP2B LUZP1 PHC2 PCGF6 NEO1 CEP120 MDC1 NAV3 NAV1 ADGRL2 PLEKHA7	2.59e-07	1345	126	21	EFO_0010736
Disease	cortical thickness	NPM1 MAGI1 MYCBP2 MAPT FAM178B TNRC6B NCKAP5 TACC2 STOX1 JMJD1C LUZP1 NEO1 CEP120 NAV3 NAV1 NUCKS1 PLEKHA7	5.40e-06	1113	126	17	EFO_0004840
Disease	alcohol consumption measurement	NOLC1 MAGI1 RC3H2 TSHZ2 MAPT NCKAP5 REST RFC1 WDR43 PHC2 CFDP1 CXXC4 NUCKS1 ASXL2 PEAK1 ADGRL2 TET3 GABRA2	5.75e-06	1242	126	18	EFO_0007878
Disease	neuroimaging measurement	MAGI1 MAPT APC TNRC6B NCKAP5 TACC2 JMJD1C LUZP1 EFTUD2 NEFM NEO1 SYCP1 NAV3 NUCKS1 RAPGEF2 PLEKHA7	1.34e-05	1069	126	16	EFO_0004346
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	NOLC1 TSHZ2 MAPT TACC2 REST TFAP2B PHC2 PCGF6 NUCKS1 HERC1 ADGRL2 TET3 GABRA2	4.02e-05	801	126	13	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Paroxysmal atrial fibrillation	MAPT NACA HIP1R PPP2R3A NUCKS1 HERC1	5.79e-05	156	126	6	C0235480
Disease	familial atrial fibrillation	MAPT NACA HIP1R PPP2R3A NUCKS1 HERC1	5.79e-05	156	126	6	C3468561
Disease	Persistent atrial fibrillation	MAPT NACA HIP1R PPP2R3A NUCKS1 HERC1	5.79e-05	156	126	6	C2585653
Disease	Atrial Fibrillation	MAPT NACA HIP1R PPP2R3A NUCKS1 HERC1	6.67e-05	160	126	6	C0004238
Disease	Endometrioma	MTA2 ABI3BP CD55 NEFM RASGRP1 LMOD1	6.90e-05	161	126	6	C0269102
Disease	Endometriosis	MTA2 ABI3BP CD55 NEFM RASGRP1 LMOD1	6.90e-05	161	126	6	C0014175
Disease	docosahexaenoic acid to total fatty acids percentage	MAPT JMJD1C MYRF	9.56e-05	21	126	3	EFO_0022262
Disease	juvenile-onset Parkinson's disease (implicated_via_orthology)	ATP13A5 ATP13A3	1.08e-04	4	126	2	DOID:0060893 (implicated_via_orthology)
Disease	Kufor-Rakeb syndrome (implicated_via_orthology)	ATP13A5 ATP13A3	1.08e-04	4	126	2	DOID:0060556 (implicated_via_orthology)
Disease	Splenomegaly	MAPT APC AHR	1.10e-04	22	126	3	C0038002
Disease	Acute Myeloid Leukemia, M1	NPM1 NUP98 RASGRP1 LPP ASXL2	2.04e-04	125	126	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	NPM1 NUP98 RASGRP1 LPP ASXL2	2.04e-04	125	126	5	C1879321
Disease	hypertension (implicated_via_orthology)	FN1 ADD3 H2AX PLEKHA7 NOS1	2.28e-04	128	126	5	DOID:10763 (implicated_via_orthology)
Disease	Treacher Collins syndrome (implicated_via_orthology)	NOLC1 EFTUD2	2.68e-04	6	126	2	DOID:2908 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	ATP13A5 NEFM ATP13A3	2.84e-04	30	126	3	DOID:332 (implicated_via_orthology)
Disease	proteinuria (implicated_via_orthology)	CD55 NCKAP5 ADD3	2.84e-04	30	126	3	DOID:576 (implicated_via_orthology)
Disease	Glioblastoma	FN1 APC BRD2 H2AX	3.72e-04	79	126	4	C0017636
Disease	Anemia	NUP98 PARP1 HP	4.13e-04	34	126	3	C0002871
Disease	Giant Cell Glioblastoma	FN1 APC BRD2 H2AX	4.70e-04	84	126	4	C0334588
Disease	cocaine use disorder, social environment measurement	TRDN ADGRL2	4.98e-04	8	126	2	EFO_0010445, EFO_0010552
Disease	Acute erythroleukemia - M6a subtype	NPM1 NUP98	4.98e-04	8	126	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	NPM1 NUP98	4.98e-04	8	126	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	NPM1 NUP98	4.98e-04	8	126	2	C2930977
Disease	Acute erythroleukemia	NPM1 NUP98	4.98e-04	8	126	2	C2930974
Disease	transient cerebral ischemia (biomarker_via_orthology)	ANK2 WNK1 NEFM PARP1 PTPN13	5.82e-04	157	126	5	DOID:224 (biomarker_via_orthology)
Disease	eosinophil count	LIMA1 MAPT SF3A1 REST STOX1 WNK1 TFAP2B ADD3 PHC2 RASGRP1 LPP AHR PCNX1 PEAK1 MYRF TET3	6.12e-04	1488	126	16	EFO_0004842
Disease	degree of unsaturation measurement	JMJD1C PCIF1 MYRF	6.21e-04	39	126	3	EFO_0022261
Disease	dyslexia	MAPT PCGF6 PPP2R3A LPP ADGRL2	6.71e-04	162	126	5	EFO_0005424
Disease	aortic measurement	TNRC6B MORC2 JMJD1C CEP120 CFDP1 NAV1	7.51e-04	251	126	6	EFO_0020865
Disease	tauopathy (implicated_via_orthology)	MAP4 MAPT	7.96e-04	10	126	2	DOID:680 (implicated_via_orthology)
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	ANK2 TRDN	7.96e-04	10	126	2	C1631597
Disease	Leukemia, Myelocytic, Acute	NPM1 NUP98 RASGRP1 LPP ASXL2	9.01e-04	173	126	5	C0023467
Disease	Adenoid Cystic Carcinoma	MAGI1 BCORL1 JMJD1C SON	9.06e-04	100	126	4	C0010606
Disease	Alzheimer disease, polygenic risk score	ZAN HIP1R CD55 TACC2 CLIP1 FSIP2 PPP2R3A RAPGEF2 HYDIN	9.52e-04	586	126	9	EFO_0030082, MONDO_0004975
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	TNRC6B ADGRL2	9.70e-04	11	126	2	EFO_0004471, EFO_0009131
Disease	Weight Gain	MAP4 MAPT AHR DYNC1LI2	9.75e-04	102	126	4	C0043094
Disease	systolic blood pressure change measurement	GABBR2 PLEKHA7 MYRF	1.07e-03	47	126	3	EFO_0006944
Disease	atrial fibrillation	MAPT NACA HIP1R JMJD1C PPP2R3A NUCKS1 HERC1	1.10e-03	371	126	7	EFO_0000275
Disease	Glioblastoma Multiforme	FN1 APC BRD2 H2AX	1.33e-03	111	126	4	C1621958
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	JMJD1C PCIF1 MYRF	1.36e-03	51	126	3	EFO_0022302
Disease	Short Rib-Polydactyly Syndrome	KIAA0586 CEP120	1.37e-03	13	126	2	C0036996
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MORC2 WNK1	1.37e-03	13	126	2	C0270914
Disease	triglycerides to total lipids in very large VLDL percentage	JMJD1C PCIF1 MYRF	1.52e-03	53	126	3	EFO_0022340
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A5 ATP13A3	1.59e-03	14	126	2	DOID:14503 (implicated_via_orthology)
Disease	Saldino-Noonan Syndrome	KIAA0586 CEP120	1.59e-03	14	126	2	C0036069
Disease	Majewski Syndrome	KIAA0586 CEP120	1.59e-03	14	126	2	C0024507
Disease	Pneumonia	PARP1 AHR IL6ST	1.61e-03	54	126	3	C0032285
Disease	Lobar Pneumonia	PARP1 AHR IL6ST	1.61e-03	54	126	3	C0032300
Disease	Pneumonitis	PARP1 AHR IL6ST	1.61e-03	54	126	3	C3714636
Disease	Experimental Lung Inflammation	PARP1 AHR IL6ST	1.61e-03	54	126	3	C0887898
Disease	retinal vasculature measurement	NCKAP5 BARX2 LUZP1 MYOF PPP2R3A CFDP1 NAV3 LMOD1	1.74e-03	517	126	8	EFO_0010554
Disease	cholesteryl esters to total lipids in large VLDL percentage	JMJD1C PCIF1 MYRF	1.79e-03	56	126	3	EFO_0022250
Disease	anemia (implicated_via_orthology)	APC SLC4A3	1.83e-03	15	126	2	DOID:2355 (implicated_via_orthology)
Disease	free cholesterol to total lipids in medium VLDL percentage	JMJD1C PCIF1 MYRF	1.88e-03	57	126	3	EFO_0022284
Disease	Atherosclerosis	PARP1 HP AHR	2.08e-03	59	126	3	C0004153
Disease	Atherogenesis	PARP1 HP AHR	2.08e-03	59	126	3	C1563937
Disease	free cholesterol to total lipids in very large VLDL percentage	JMJD1C PCIF1 MYRF	2.08e-03	59	126	3	EFO_0022289
Disease	Romano-Ward Syndrome	ANK2 TRDN	2.09e-03	16	126	2	C0035828
Disease	acylcarnitine measurement	SLC1A7 PCIF1 HERC1 MYRF	2.19e-03	127	126	4	EFO_0005059
Disease	Malignant neoplasm of breast	FN1 ANK2 BCORL1 NUP98 TACC2 WNK1 CLIP1 PARP1 HP ANKEF1 AHR H2AX	2.21e-03	1074	126	12	C0006142
Disease	acute kidney failure (biomarker_via_orthology)	FN1 HP NOS1	2.28e-03	61	126	3	DOID:3021 (biomarker_via_orthology)
Disease	waist-hip ratio	FN1 MYCBP2 TSHZ2 MAPT HIP1R TNRC6B WNK1 TFAP2B JMJD1C PPP2R3A NAV3 PCNX1 BARX1	2.29e-03	1226	126	13	EFO_0004343
Disease	phosphatidylcholine 40:6 measurement	RAPGEF2 MYRF	2.36e-03	17	126	2	EFO_0010389
Disease	Acute myeloid leukemia	NPM1 LPP	2.36e-03	17	126	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	NPM1 LPP	2.36e-03	17	126	2	601626
Disease	Fetal Alcohol Syndrome	REST NOS1	2.36e-03	17	126	2	C0015923
Disease	diastolic blood pressure, systolic blood pressure	ANK2 RBM33 TNRC6B WDR43 ZNF512B KIAA1671 RASGRP1 CEP120 NAV1	2.38e-03	670	126	9	EFO_0006335, EFO_0006336
Disease	Tinnitus	MAGI1 DCP2 TNRC6B PTPN13	2.38e-03	130	126	4	HP_0000360
Disease	oral squamous cell carcinoma (is_marker_for)	PTPN13 HP H2AX	2.50e-03	63	126	3	DOID:0050866 (is_marker_for)
Disease	Allergic Reaction	IL16 HP IL6ST	2.50e-03	63	126	3	C1527304
Disease	Alzheimer's disease (is_implicated_in)	MAPT NEFM PARP1 NOS1	2.51e-03	132	126	4	DOID:10652 (is_implicated_in)
Disease	pulse pressure measurement	RC3H2 FN1 ANK2 RBM33 LCA5L TNRC6B LUZP1 PHC2 CEP120 LPP CFDP1 NAV1 PLEKHA7 HYDIN	2.52e-03	1392	126	14	EFO_0005763
Disease	transient cerebral ischemia (implicated_via_orthology)	PARP1 H2AX NOS1	2.62e-03	64	126	3	DOID:224 (implicated_via_orthology)
Disease	Hypersensitivity	IL16 HP IL6ST	2.62e-03	64	126	3	C0020517
Disease	borna disease (biomarker_via_orthology)	IL16 PARP1	2.65e-03	18	126	2	DOID:5154 (biomarker_via_orthology)
Disease	sexual dimorphism measurement	LIMA1 APC REST CLIP1 JMJD1C CEP120 CASKIN1 PCIF1 NUCKS1 ASXL2 HERC1 MYRF	2.80e-03	1106	126	12	EFO_0021796
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	PCIF1 MYRF	2.95e-03	19	126	2	EFO_0004612, EFO_0008589
Disease	renovascular hypertension (biomarker_via_orthology)	EIF4G2 NOS1	2.95e-03	19	126	2	DOID:1591 (biomarker_via_orthology)
Disease	ascending aortic diameter	TNRC6B JMJD1C CEP120 HYDIN	3.11e-03	140	126	4	EFO_0021787
Disease	Colorectal Carcinoma	FN1 ANK2 SF3A1 APC WNK1 SLC1A7 PARP1 CCNB3 IL6ST	3.24e-03	702	126	9	C0009402
Disease	triglycerides to total lipids in very small VLDL percentage	JMJD1C PCIF1 MYRF	3.24e-03	69	126	3	EFO_0022341
Disease	coronary artery calcification	MAGI1 ABI3BP SF3A1 FSIP2 EIF4G2 PCIF1 NAV3	3.27e-03	450	126	7	EFO_0004723
Disease	blood urea nitrogen measurement	TFAP2B SLC1A7 PHC2 PPP2R3A AHR ASXL2 ADGRL2	3.35e-03	452	126	7	EFO_0004741
Disease	haptoglobin measurement	HP HYDIN	3.60e-03	21	126	2	EFO_0004640
Disease	Joubert syndrome 1	KIAA0586 CEP120	3.60e-03	21	126	2	C4551568
Disease	free cholesterol to total lipids in large LDL percentage	JMJD1C PCIF1 MYRF	3.95e-03	74	126	3	EFO_0022280
Disease	asthma, endometriosis	FN1 EFTUD2 LPP	3.95e-03	74	126	3	EFO_0001065, MONDO_0004979
Disease	upper aerodigestive tract neoplasm	NCKAP5 WNK1 FAN1 EIF4G2 ADGRL2	4.17e-03	246	126	5	EFO_0004284
Disease	Parkinson's disease (is_implicated_in)	MAPT PARP1 NOS1	4.26e-03	76	126	3	DOID:14330 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KTVKPIPAEGIKSNP	AHR	21	P35869
KKEKTSAPPSEGTPP	SLC4A3	111	P48751
NIIKPGPKASKSPVE	ATP13A5	576	Q4VNC0
VLSPEGSPSKSPSKK	ADD3	671	Q9UEY8
PPKPQTTTEAKALVK	ATP13A3	1201	Q9H7F0
SGVSPKPDPKTISKH	RASGRP1	456	O95267
SQQKTRSPKSPTPVK	BCORL1	1441	Q5H9F3
KSASSPKPDTKVPQV	CEND1	6	Q8N111
PKPDTKVPQVTTEAK	CEND1	11	Q8N111
SKGTKPPPAVSTTKI	ADGRL2	441	O95490
GKTPPILKTEGPEIK	ANKEF1	661	Q9NU02
IIPGIPKDTKFNPKT	DCP2	176	Q8IU60
LVTSPSKPKSPGVEK	ASXL2	521	Q76L83
DKPVSPQAKGTPKEI	CCNB3	1096	Q8WWL7
SVIKKVPVPPKSVTS	TFAP2B	196	Q92481
QEKTPKTPKGPSSVE	NPM1	231	P06748
SVTENKIGSPPKTPV	RC3H2	541	Q9HBD1
KTEVKVKPASPVAQP	RBM33	756	Q96EV2
AQAPLKPKTPRGTKT	MTA2	526	O94776
KITPVTVKAQTKAPP	NOLC1	186	Q14978
TKAVVSKATTKPPPA	NOLC1	341	Q14978
TVNPGTKSKLPKPVQ	PARP1	656	P09874
GDVPSPKSKIPSKNV	KIAA1549	1391	Q9HCM3
SGKTEKQPPVSPTSK	ANK2	1966	Q01484
PEKKTSTSPPPEKSG	NUCKS1	216	Q9H1E3
KSSKPPQKEPVEKGS	REST	591	Q13127
VPKLQGSPTPTSKKV	CASKIN1	1236	Q8WXD9
TKKLKTAPLPPASQT	NUP98	901	P52948
KTNRSSVKTPKPVEP	MDC1	1641	Q14676
PKPKQIRISSKTGIP	LTV1	371	Q96GA3
KPPSQPVSGKVITTD	MAGI1	191	Q96QZ7
SPEKKTKPLATTQPA	MAP4	696	P27816
SSQGPSKKKPPVETR	MAJIN	86	Q3KP22
STVPEKKTPKSPVGV	HP	316	P00738
VTGNGIVLPPKPKSK	KIAA0895	191	Q8NCT3
RVSPKSPPTDQKKGT	KIAA1671	1361	Q9BY89
SPPTDQKKGTPRKST	KIAA1671	1366	Q9BY89
SVKSPKTVSPPIRKG	LIMA1	601	Q9UHB6
KPSLGKSTIKTNTPI	MTUS1	476	Q9ULD2
PISPLKTGVSKPIVK	ANLN	321	Q9NQW6
IKSSPSPEVVKPKIT	JMJD1C	636	Q15652
NSTGPITKPKKVSGL	HERC1	701	Q15751
TKPKGRPKKNSIPTS	BARX1	211	Q9HBU1
KSLTSKVPPTVQKPT	CD55	286	P08174
PPSTKKSGQKPVLDV	DYNC1LI1	481	Q9Y6G9
SSPGTSVKKPDPNIK	DYNC1LI2	406	O43237
KAKPVAPVSSKTPST	FSIP2	1556	Q5CZC0
TISKSATTPEPNKKP	GABRA2	386	P47869
LLPKKTSATVGPKAP	H2AX	116	P16104
QPPTKSGKSKPLKAE	PCNX1	351	Q96RV3
GSSKPKETVPTLAPK	PCNP	91	Q8WW12
SKTKTPEKQTPSGPT	LMOD1	286	P29536
DSPTTKVQKDPSIKP	PEAK1	836	Q9H792
KVQKDPSIKPVTPSP	PEAK1	841	Q9H792
KKESLIPSSSGIPKP	NAV3	516	Q8IVL0
GIPKPGSKVPTVKQT	NAV3	526	Q8IVL0
PAKSPVGRSKTEKPT	FAM205A	1256	Q6ZU69
SSTVKKGPPVAPKPA	IL16	776	Q14005
PLTATKKSTLKPQPA	LPP	171	Q93052
GTQKSDVPPLTTKGK	LCA5L	376	O95447
QKSVPKEVPPGTKSS	GGA2	436	Q9UJY4
NTVLPKPDLPKTSGK	F8	1496	P00451
TNPPLIQEKPAKTSK	EIF4G2	521	P78344
PKSKVSSPIEKVSPS	PPP2R3A	556	Q06190
KEIPQKTKGQESPTP	OOSP4B	121	A0A2R8Y4Y8
KKTEPPGSITKVFPS	HEMGN	106	Q9BXL5
VTKKPTSQIPETKHP	MYBBP1A	486	Q9BQG0
KKTESPIKLSPATPS	MORC2	721	Q9Y6X9
EKEQPPTSGKQSPTK	NOS1	281	P29475
VGPKSKVPPSTQVKK	CFDP1	121	Q9UEE9
RSVTTKKPPLAQKPS	HIP1R	1031	O75146
SVQPKKGSLTPTEKP	HYDIN	3101	Q4G0P3
QAPPSKGPTVRTKKV	IL6ST	516	P40189
KKPKIEIPVTPTGQS	PCIF1	126	Q9H4Z3
TKTTPVVKSPKVAPE	SLC1A7	161	O00341
KPVGKISSTSVKPKP	CAPN7	156	Q9Y6W3
KEKTLTGPKSPTVSP	CEP120	371	Q8N960
TTTPKNGPGPTKTKT	FN1	1666	P02751
TKPKGRPKKNSIPTS	BARX2	201	Q9UMQ3
KKKPGTSLERTPVPS	CXXC4	176	Q9H2H0
TTLEKQKPVSKPGPN	LUZP1	776	Q86V48
PLSSKQIKTISGKTP	GABBR2	321	O75899
QIPSKPKTKLGSRTT	CCDC168	256	Q8NDH2
SGKPEPVSSVKTEPK	GPRIN1	126	Q7Z2K8
LTPTTVPPKNAKAKI	CFAP47	3131	Q6ZTR5
PSGLKAPTKILKPGS	CLIP1	6	P30622
QFKTSGPEKKPIPGI	PTPN13	276	Q12923
SQPKEKISKVPSTPV	PTPN13	1176	Q12923
TKGKNTPVPEKPTEN	MUCL3	321	Q3MIW9
VPQPVPSSKGRSKKV	PCGF6	226	Q9BYE7
ETPPSKKAGSQKPTP	NYAP1	136	Q6ZVC0
PGSLKKGKTPPVAVT	NAV1	526	Q8NEY1
DVTPKKSPPPKTNLT	FAN1	96	Q9Y2M0
TKPPKTTNPSKISGI	SLITRK4	301	Q8IW52
PSPSGPKKKTTKVAE	VCY	26	O14598
TKIPPRGKSSPQKSK	NCKAP5	801	O14513
TKPTSVEAKQKPGPS	NCKAP5	1491	O14513
KNKPLSPIKLTPTSV	RFC1	151	P35251
PTSPKKPKIQAPGET	FAM178B	91	Q8IXR5
SPPKDVTVVSKEGKP	NEO1	956	Q92859
VTSPLQSPTKAKPKV	PLEKHA7	901	Q6IQ23
ETSGKPKTTPKRKPA	SMN1	61	Q16637
PQKSTAPVKTKLDPP	MYCBP2	2851	O75592
TKEKIGPSKPNEIPQ	SF3A1	541	Q15459
PKPAGVAVKTPTEKV	DZIP1	736	Q86YF9
SGTKLPKKATKTAPP	BRD2	611	P25440
IPATVPEGKKQGKSP	BCO1	201	Q9HAY6
VSKKGPPLKTPASKS	APC	2246	P25054
CSPVSSVRKKPKVTP	DNTTIP2	116	Q5QJE6
PGDKKPVKSETSPVA	RAPGEF2	1011	Q9Y4G8
PPLTKDTKKQPTGTV	PHC2	706	Q8IXK0
VSTKLISKSNPTPKP	UBN2	1071	Q6ZU65
TTPKVVTKPGHIIKP	UTP14C	716	Q5TAP6
LTQVTTEPPTQKPKK	CLEC3B	16	P05452
VKTPKKAPSSLTTPG	SYCP1	926	Q15431
TSDLKPSQTGPKEKP	STOX1	516	Q6ZVD7
PPGKPSTSEKINKTS	SSX7	141	Q7RTT5
PPGKPTTSEKINKAS	SSX9P	141	Q7RTT3
KTSVKPSQPKESDIP	TXNDC2	226	Q86VQ3
KKVAVVRTPPKSPSS	MAPT	541	P10636
TKKPTETPPVKETQQ	TACC2	2141	O95359
TKPKVKVEAPSSSPA	TET3	486	O43151
QKVPLKEPVPTISSK	TSHZ2	301	Q9NRE2
KKVGSEKPGTTLPQP	ZNF598	591	Q86UK7
KPITVTKSVPVTKPV	ZNF512B	256	Q96KM6
VTKPVPVTKPITVTK	ZNF512B	266	Q96KM6
SIKTDKPKPTPKGTS	TRDN	591	Q13061
KPKPTPKGTSEVTES	TRDN	596	Q13061
QVPAKDPKPSFTVKT	VSIG10L	126	Q86VR7
KITDTKKEGPVASPP	WNK1	1966	Q9H4A3
TQPLTEPIIKPVKTK	EFTUD2	86	Q15029
VPKVPQRVTAKPKTS	ABI3BP	551	Q7Z7G0
KPTPPKSQVTLTKEF	SON	2161	P18583
PPSSRKVETGVKKPN	KIAA0586	766	Q9BVV6
KTKVPEVTKPSLSQP	TNRC6B	36	Q9UPQ9
EPPKKEAATTGPQVK	ZC3H18	496	Q86VM9
TIQIATPGKGKKSTP	WDR43	316	Q15061
KPSVTTEKPTVPKEK	ZAN	576	Q9Y493
VSPQTKRPPTKKGSA	NACA	801	E9PAV3
NIPKTKFGKPDPIVS	MYOF	11	Q9NZM1
TPTSPIKKFPTTATK	PPP1R12A	406	O14974
KRPPKVASKSSSVVP	MYRF	741	Q9Y2G1
VPKSPVEEKGKSPVS	NEFM	656	P07197